FALSE2020FY0001037868us-gaap:AccountingStandardsUpdate201613Memberus-gaap:AccountingStandardsUpdate201613Memberus-gaap:AccountingStandardsUpdate201613MemberP3YP5YP9YP10YP2Y11422525252533.3333.3333.3333.3333.3333.33us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentus-gaap:AccountsPayableAndAccruedLiabilitiesCurrentus-gaap:OtherLiabilitiesNoncurrentus-gaap:OtherLiabilitiesNoncurrent00010378682020-01-012020-12-31iso4217:USD00010378682020-06-30xbrli:shares00010378682021-01-2900010378682019-01-012019-12-3100010378682018-01-012018-12-31iso4217:USDxbrli:shares00010378682020-12-3100010378682019-12-3100010378682018-12-310001037868us-gaap:CommonStockMember2019-12-310001037868us-gaap:CommonStockMember2018-12-310001037868us-gaap:CommonStockMember2017-12-310001037868us-gaap:CommonStockMember2020-01-012020-12-310001037868us-gaap:CommonStockMember2019-01-012019-12-310001037868us-gaap:CommonStockMember2018-01-012018-12-310001037868us-gaap:CommonStockMember2020-12-310001037868us-gaap:AdditionalPaidInCapitalMember2019-12-310001037868us-gaap:AdditionalPaidInCapitalMember2018-12-310001037868us-gaap:AdditionalPaidInCapitalMember2017-12-310001037868us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001037868us-gaap:AdditionalPaidInCapitalMember2019-01-012019-12-310001037868us-gaap:AdditionalPaidInCapitalMember2018-01-012018-12-310001037868us-gaap:AdditionalPaidInCapitalMember2020-12-310001037868us-gaap:RetainedEarningsMember2019-12-310001037868us-gaap:RetainedEarningsMember2018-12-310001037868us-gaap:RetainedEarningsMember2017-12-310001037868us-gaap:RetainedEarningsMember2020-01-012020-12-310001037868us-gaap:RetainedEarningsMember2019-01-012019-12-310001037868us-gaap:RetainedEarningsMember2018-01-012018-12-310001037868us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-12-310001037868us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001037868us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2018-12-310001037868us-gaap:RetainedEarningsMember2020-12-310001037868us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001037868us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310001037868us-gaap:AccumulatedTranslationAdjustmentMember2017-12-310001037868us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-12-310001037868us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-12-310001037868us-gaap:AccumulatedTranslationAdjustmentMember2018-01-012018-12-310001037868us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001037868us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310001037868us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-12-310001037868us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2017-12-310001037868us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-12-310001037868us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-01-012019-12-310001037868us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-01-012018-12-310001037868us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310001037868us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-12-310001037868us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2018-12-310001037868us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2017-12-310001037868us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-012020-12-310001037868us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-01-012019-12-310001037868us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2018-01-012018-12-310001037868us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310001037868us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001037868us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001037868us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001037868us-gaap:TreasuryStockMember2019-12-310001037868us-gaap:TreasuryStockMember2018-12-310001037868us-gaap:TreasuryStockMember2017-12-310001037868us-gaap:TreasuryStockMember2020-01-012020-12-310001037868us-gaap:TreasuryStockMember2019-01-012019-12-310001037868us-gaap:TreasuryStockMember2018-01-012018-12-310001037868us-gaap:TreasuryStockMember2020-12-3100010378682017-12-31xbrli:pure0001037868srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2020-01-012020-12-310001037868us-gaap:MachineryAndEquipmentMembersrt:MaximumMember2020-01-012020-12-310001037868srt:MinimumMemberus-gaap:LeaseholdImprovementsMember2020-01-012020-12-310001037868us-gaap:LeaseholdImprovementsMembersrt:MaximumMember2020-01-012020-12-310001037868us-gaap:BuildingMembersrt:MinimumMember2020-01-012020-12-310001037868us-gaap:BuildingMembersrt:MaximumMember2020-01-012020-12-310001037868ame:PatentsAndTechnologyMembersrt:MinimumMember2020-01-012020-12-310001037868ame:PatentsAndTechnologyMembersrt:MaximumMember2020-01-012020-12-310001037868ame:PatentsAndTechnologyMember2020-01-012020-12-310001037868srt:MinimumMemberus-gaap:CustomerRelationshipsMember2020-01-012020-12-310001037868us-gaap:CustomerRelationshipsMembersrt:MaximumMember2020-01-012020-12-310001037868us-gaap:CustomerRelationshipsMember2020-01-012020-12-31ame:unit_Operation0001037868us-gaap:ShippingAndHandlingMember2020-01-012020-12-310001037868us-gaap:ShippingAndHandlingMember2019-01-012019-12-310001037868us-gaap:ShippingAndHandlingMember2018-01-012018-12-310001037868srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-12-310001037868us-gaap:OtherNoncurrentLiabilitiesMember2020-12-310001037868us-gaap:OtherNoncurrentLiabilitiesMember2019-12-3100010378682021-01-012020-12-3100010378682020-01-012019-12-310001037868srt:MinimumMember2021-01-012020-12-3100010378682021-01-01srt:MaximumMember2020-12-310001037868country:USame:ElectronicInstrumentsGroupMember2020-01-012020-12-310001037868ame:ElectromechanicalGroupMembercountry:US2020-01-012020-12-310001037868country:US2020-01-012020-12-310001037868country:GBame:ElectronicInstrumentsGroupMember2020-01-012020-12-310001037868country:GBame:ElectromechanicalGroupMember2020-01-012020-12-310001037868country:GB2020-01-012020-12-310001037868us-gaap:EuropeanUnionMemberame:ElectronicInstrumentsGroupMember2020-01-012020-12-310001037868ame:ElectromechanicalGroupMemberus-gaap:EuropeanUnionMember2020-01-012020-12-310001037868us-gaap:EuropeanUnionMember2020-01-012020-12-310001037868srt:AsiaMemberame:ElectronicInstrumentsGroupMember2020-01-012020-12-310001037868srt:AsiaMemberame:ElectromechanicalGroupMember2020-01-012020-12-310001037868srt:AsiaMember2020-01-012020-12-310001037868ame:OtherForeignCountriesMemberame:ElectronicInstrumentsGroupMember2020-01-012020-12-310001037868ame:OtherForeignCountriesMemberame:ElectromechanicalGroupMember2020-01-012020-12-310001037868ame:OtherForeignCountriesMember2020-01-012020-12-310001037868ame:InternationalMemberame:ElectronicInstrumentsGroupMember2020-01-012020-12-310001037868ame:InternationalMemberame:ElectromechanicalGroupMember2020-01-012020-12-310001037868ame:InternationalMember2020-01-012020-12-310001037868ame:ElectronicInstrumentsGroupMember2020-01-012020-12-310001037868ame:ElectromechanicalGroupMember2020-01-012020-12-310001037868us-gaap:NonUsMember2020-01-012020-12-310001037868country:USame:ElectronicInstrumentsGroupMember2019-01-012019-12-310001037868ame:ElectromechanicalGroupMembercountry:US2019-01-012019-12-310001037868country:US2019-01-012019-12-310001037868country:GBame:ElectronicInstrumentsGroupMember2019-01-012019-12-310001037868country:GBame:ElectromechanicalGroupMember2019-01-012019-12-310001037868country:GB2019-01-012019-12-310001037868us-gaap:EuropeanUnionMemberame:ElectronicInstrumentsGroupMember2019-01-012019-12-310001037868ame:ElectromechanicalGroupMemberus-gaap:EuropeanUnionMember2019-01-012019-12-310001037868us-gaap:EuropeanUnionMember2019-01-012019-12-310001037868srt:AsiaMemberame:ElectronicInstrumentsGroupMember2019-01-012019-12-310001037868srt:AsiaMemberame:ElectromechanicalGroupMember2019-01-012019-12-310001037868srt:AsiaMember2019-01-012019-12-310001037868ame:OtherForeignCountriesMemberame:ElectronicInstrumentsGroupMember2019-01-012019-12-310001037868ame:OtherForeignCountriesMemberame:ElectromechanicalGroupMember2019-01-012019-12-310001037868ame:OtherForeignCountriesMember2019-01-012019-12-310001037868ame:InternationalMemberame:ElectronicInstrumentsGroupMember2019-01-012019-12-310001037868ame:InternationalMemberame:ElectromechanicalGroupMember2019-01-012019-12-310001037868ame:InternationalMember2019-01-012019-12-310001037868ame:ElectronicInstrumentsGroupMember2019-01-012019-12-310001037868ame:ElectromechanicalGroupMember2019-01-012019-12-310001037868us-gaap:NonUsMember2019-01-012019-12-310001037868country:USame:ElectronicInstrumentsGroupMember2018-01-012018-12-310001037868ame:ElectromechanicalGroupMembercountry:US2018-01-012018-12-310001037868country:US2018-01-012018-12-310001037868country:GBame:ElectronicInstrumentsGroupMember2018-01-012018-12-310001037868country:GBame:ElectromechanicalGroupMember2018-01-012018-12-310001037868country:GB2018-01-012018-12-310001037868us-gaap:EuropeanUnionMemberame:ElectronicInstrumentsGroupMember2018-01-012018-12-310001037868ame:ElectromechanicalGroupMemberus-gaap:EuropeanUnionMember2018-01-012018-12-310001037868us-gaap:EuropeanUnionMember2018-01-012018-12-310001037868srt:AsiaMemberame:ElectronicInstrumentsGroupMember2018-01-012018-12-310001037868srt:AsiaMemberame:ElectromechanicalGroupMember2018-01-012018-12-310001037868srt:AsiaMember2018-01-012018-12-310001037868ame:OtherForeignCountriesMemberame:ElectronicInstrumentsGroupMember2018-01-012018-12-310001037868ame:OtherForeignCountriesMemberame:ElectromechanicalGroupMember2018-01-012018-12-310001037868ame:OtherForeignCountriesMember2018-01-012018-12-310001037868ame:InternationalMemberame:ElectronicInstrumentsGroupMember2018-01-012018-12-310001037868ame:InternationalMemberame:ElectromechanicalGroupMember2018-01-012018-12-310001037868ame:InternationalMember2018-01-012018-12-310001037868ame:ElectronicInstrumentsGroupMember2018-01-012018-12-310001037868ame:ElectromechanicalGroupMember2018-01-012018-12-310001037868us-gaap:NonUsMember2018-01-012018-12-310001037868ame:ElectronicInstrumentsGroupMemberame:ProcessAndAnalyticalInstrumentationMember2020-01-012020-12-310001037868ame:ElectromechanicalGroupMemberame:ProcessAndAnalyticalInstrumentationMember2020-01-012020-12-310001037868ame:ProcessAndAnalyticalInstrumentationMember2020-01-012020-12-310001037868ame:AerospaceAndPowerMemberame:ElectronicInstrumentsGroupMember2020-01-012020-12-310001037868ame:AerospaceAndPowerMemberame:ElectromechanicalGroupMember2020-01-012020-12-310001037868ame:AerospaceAndPowerMember2020-01-012020-12-310001037868ame:AutomationAndEngineeredSolutionsMemberame:ElectronicInstrumentsGroupMember2020-01-012020-12-310001037868ame:AutomationAndEngineeredSolutionsMemberame:ElectromechanicalGroupMember2020-01-012020-12-310001037868ame:AutomationAndEngineeredSolutionsMember2020-01-012020-12-310001037868ame:ElectronicInstrumentsGroupMemberame:ProcessAndAnalyticalInstrumentationMember2019-01-012019-12-310001037868ame:ElectromechanicalGroupMemberame:ProcessAndAnalyticalInstrumentationMember2019-01-012019-12-310001037868ame:ProcessAndAnalyticalInstrumentationMember2019-01-012019-12-310001037868ame:AerospaceAndPowerMemberame:ElectronicInstrumentsGroupMember2019-01-012019-12-310001037868ame:AerospaceAndPowerMemberame:ElectromechanicalGroupMember2019-01-012019-12-310001037868ame:AerospaceAndPowerMember2019-01-012019-12-310001037868ame:AutomationAndEngineeredSolutionsMemberame:ElectronicInstrumentsGroupMember2019-01-012019-12-310001037868ame:AutomationAndEngineeredSolutionsMemberame:ElectromechanicalGroupMember2019-01-012019-12-310001037868ame:AutomationAndEngineeredSolutionsMember2019-01-012019-12-310001037868ame:ElectronicInstrumentsGroupMemberame:ProcessAndAnalyticalInstrumentationMember2018-01-012018-12-310001037868ame:ElectromechanicalGroupMemberame:ProcessAndAnalyticalInstrumentationMember2018-01-012018-12-310001037868ame:ProcessAndAnalyticalInstrumentationMember2018-01-012018-12-310001037868ame:AerospaceAndPowerMemberame:ElectronicInstrumentsGroupMember2018-01-012018-12-310001037868ame:AerospaceAndPowerMemberame:ElectromechanicalGroupMember2018-01-012018-12-310001037868ame:AerospaceAndPowerMember2018-01-012018-12-310001037868ame:AutomationAndEngineeredSolutionsMemberame:ElectronicInstrumentsGroupMember2018-01-012018-12-310001037868ame:AutomationAndEngineeredSolutionsMemberame:ElectromechanicalGroupMember2018-01-012018-12-310001037868ame:AutomationAndEngineeredSolutionsMember2018-01-012018-12-310001037868us-gaap:TransferredAtPointInTimeMemberame:ElectronicInstrumentsGroupMember2020-01-012020-12-310001037868us-gaap:TransferredAtPointInTimeMemberame:ElectromechanicalGroupMember2020-01-012020-12-310001037868us-gaap:TransferredAtPointInTimeMember2020-01-012020-12-310001037868us-gaap:TransferredOverTimeMemberame:ElectronicInstrumentsGroupMember2020-01-012020-12-310001037868us-gaap:TransferredOverTimeMemberame:ElectromechanicalGroupMember2020-01-012020-12-310001037868us-gaap:TransferredOverTimeMember2020-01-012020-12-310001037868us-gaap:TransferredAtPointInTimeMemberame:ElectronicInstrumentsGroupMember2019-01-012019-12-310001037868us-gaap:TransferredAtPointInTimeMemberame:ElectromechanicalGroupMember2019-01-012019-12-310001037868us-gaap:TransferredAtPointInTimeMember2019-01-012019-12-310001037868us-gaap:TransferredOverTimeMemberame:ElectronicInstrumentsGroupMember2019-01-012019-12-310001037868us-gaap:TransferredOverTimeMemberame:ElectromechanicalGroupMember2019-01-012019-12-310001037868us-gaap:TransferredOverTimeMember2019-01-012019-12-310001037868us-gaap:TransferredAtPointInTimeMemberame:ElectronicInstrumentsGroupMember2018-01-012018-12-310001037868us-gaap:TransferredAtPointInTimeMemberame:ElectromechanicalGroupMember2018-01-012018-12-310001037868us-gaap:TransferredAtPointInTimeMember2018-01-012018-12-310001037868us-gaap:TransferredOverTimeMemberame:ElectronicInstrumentsGroupMember2018-01-012018-12-310001037868us-gaap:TransferredOverTimeMemberame:ElectromechanicalGroupMember2018-01-012018-12-310001037868us-gaap:TransferredOverTimeMember2018-01-012018-12-310001037868us-gaap:FairValueMeasurementsRecurringMember2020-12-310001037868us-gaap:FairValueMeasurementsRecurringMember2019-12-310001037868us-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310001037868us-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001037868us-gaap:CarryingReportedAmountFairValueDisclosureMember2019-12-310001037868us-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-31iso4217:CAD0001037868us-gaap:ForeignExchangeForwardMember2019-12-310001037868us-gaap:ForeignExchangeForwardMember2019-01-012019-12-310001037868us-gaap:ForeignExchangeForwardMember2018-12-310001037868us-gaap:ForeignExchangeForwardMember2018-01-012018-12-310001037868ame:BritishPoundDenominatedLoansMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001037868ame:BritishPoundDenominatedLoansMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310001037868us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberame:EuroLoanMember2020-12-310001037868us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberame:EuroLoanMember2019-12-310001037868us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310001037868us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310001037868ame:A2020ConsolidatedAcquisitionMember2020-01-012020-01-310001037868ame:A2020ConsolidatedAcquisitionMember2020-12-310001037868ame:A2020ConsolidatedAcquisitionMember2020-01-012020-12-310001037868ame:PacificDesignTechnologiesIncMemberame:A2020ConsolidatedAcquisitionMember2020-12-310001037868ame:A2020ConsolidatedAcquisitionMemberus-gaap:TradeNamesMember2020-01-012020-12-310001037868ame:A2020ConsolidatedAcquisitionMemberus-gaap:CustomerRelationshipsMember2020-01-012020-12-310001037868ame:A2020ConsolidatedAcquisitionMemberus-gaap:CustomerRelationshipsMembersrt:MaximumMember2020-01-012020-12-310001037868ame:A2020ConsolidatedAcquisitionMemberame:PurchasedTechnologyMember2020-01-012020-12-310001037868srt:MinimumMemberame:A2020ConsolidatedAcquisitionMemberame:PurchasedTechnologyMember2020-01-012020-12-310001037868ame:TwoThousandAndNineteenConsolidatedAcquisitionMember2019-01-012019-12-310001037868ame:TwoThousandAndNineteenConsolidatedAcquisitionMember2020-01-012020-12-310001037868ame:TwoThousandAndNineteenConsolidatedAcquisitionMember2020-12-310001037868ame:TwoThousandAndNineteenConsolidatedAcquisitionMemberus-gaap:TradeNamesMember2020-01-012020-12-310001037868ame:TwoThousandAndNineteenConsolidatedAcquisitionMemberus-gaap:CustomerRelationshipsMember2020-01-012020-12-310001037868ame:TwoThousandAndNineteenConsolidatedAcquisitionMemberame:PurchasedTechnologyMember2020-01-012020-12-310001037868ame:TwoThousandAndEighteenConsolidatedAcquisitionMember2018-01-012018-12-310001037868ame:ReadingAlloysMemberame:KymeraInternationalMember2020-01-012020-12-3100010378682020-01-012020-03-310001037868ame:ElectronicInstrumentsGroupMember2018-12-310001037868ame:ElectromechanicalGroupMember2018-12-310001037868ame:ElectronicInstrumentsGroupMember2019-12-310001037868ame:ElectromechanicalGroupMember2019-12-310001037868ame:ElectronicInstrumentsGroupMember2020-12-310001037868ame:ElectromechanicalGroupMember2020-12-310001037868us-gaap:PatentsMember2020-12-310001037868us-gaap:PatentsMember2019-12-310001037868ame:PurchasedTechnologyMember2020-12-310001037868ame:PurchasedTechnologyMember2019-12-310001037868us-gaap:CustomerListsMember2020-12-310001037868us-gaap:CustomerListsMember2019-12-310001037868us-gaap:TrademarksAndTradeNamesMember2020-12-310001037868us-gaap:TrademarksAndTradeNamesMember2019-12-310001037868ame:NonCurrentMember2020-12-310001037868ame:NonCurrentMember2019-12-310001037868srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001037868us-gaap:ForeignCountryMember2020-12-310001037868us-gaap:ForeignCountryMember2019-12-310001037868us-gaap:StateAndLocalJurisdictionMember2020-12-310001037868us-gaap:DomesticCountryMember2020-12-310001037868ame:SeniorNotesThreePointSevenThreePercentDueSeptemberTwoThousandTwentyFourMember2014-09-300001037868ame:SeniorNotesThreePointSevenThreePercentDueSeptemberTwoThousandTwentyFourMember2020-12-310001037868ame:SeniorNotesThreePointSevenThreePercentDueSeptemberTwoThousandTwentyFourMember2019-12-310001037868ame:ThreePointNineOnePercentDueJuneTwoThousandTwentyFiveMember2015-06-300001037868ame:ThreePointNineOnePercentDueJuneTwoThousandTwentyFiveMember2020-12-310001037868ame:ThreePointNineOnePercentDueJuneTwoThousandTwentyFiveMember2019-12-310001037868ame:ThreePointNineSixPercentDueAugustTwoThousandTwentyFiveMember2015-08-310001037868ame:ThreePointNineSixPercentDueAugustTwoThousandTwentyFiveMember2020-12-310001037868ame:ThreePointNineSixPercentDueAugustTwoThousandTwentyFiveMember2019-12-310001037868ame:SeniorNotesFourPointOneEightPercentDueDecemberTwoThousendTwentyFiveMember2020-12-310001037868ame:SeniorNotesFourPointOneEightPercentDueDecemberTwoThousendTwentyFiveMember2019-12-310001037868ame:SeniorNotesThreePointEightThreePercentDueSeptemberTwoThousandTwentySixMember2014-09-300001037868ame:SeniorNotesThreePointEightThreePercentDueSeptemberTwoThousandTwentySixMember2020-12-310001037868ame:SeniorNotesThreePointEightThreePercentDueSeptemberTwoThousandTwentySixMember2019-12-310001037868ame:SeniorNotesFourPointThreeTwoPercentDueDecemberTwoThousandTwentySeven1Member2020-12-310001037868ame:SeniorNotesFourPointThreeTwoPercentDueDecemberTwoThousandTwentySeven1Member2019-12-310001037868ame:SeniorNotesFourPointThreeSevenPercentDueDecemberTwoThousendTwentyEightMember2020-12-310001037868ame:SeniorNotesFourPointThreeSevenPercentDueDecemberTwoThousendTwentyEightMember2019-12-310001037868ame:SeniorNotesThreePointNineEightPercentDueSeptemberTwoThousandTwentyNineMember2014-09-300001037868ame:SeniorNotesThreePointNineEightPercentDueSeptemberTwoThousandTwentyNineMember2020-12-310001037868ame:SeniorNotesThreePointNineEightPercentDueSeptemberTwoThousandTwentyNineMember2019-12-310001037868ame:FourPointFourFivePercentDueAugustTwoThousandThirtyFiveMember2015-08-310001037868ame:FourPointFourFivePercentDueAugustTwoThousandThirtyFiveMember2020-12-310001037868ame:FourPointFourFivePercentDueAugustTwoThousandThirtyFiveMember2019-12-310001037868ame:BritishPoundFourPointSixEightPercentSeniorNoteDueSeptemberTwoThousandTwentyMember2020-09-300001037868ame:BritishPoundFourPointSixEightPercentSeniorNoteDueSeptemberTwoThousandTwentyMember2020-12-310001037868ame:BritishPoundFourPointSixEightPercentSeniorNoteDueSeptemberTwoThousandTwentyMember2019-12-310001037868ame:BritishPoundTwoPointFiveNinePercentSeniorNoteDueNovemberTwoThousandTwentyEightMember2020-12-310001037868ame:BritishPoundTwoPointFiveNinePercentSeniorNoteDueNovemberTwoThousandTwentyEightMember2019-12-310001037868ame:BritishPoundTwoPointSevenZeroPercentSeniorNoteDueNovemberTwoThousandThirtyOneMember2020-12-310001037868ame:BritishPoundTwoPointSevenZeroPercentSeniorNoteDueNovemberTwoThousandThirtyOneMember2019-12-310001037868ame:EuroOnePointThreeFourPercentSeniorNoteDueOctoberTwoThousandTwentySixMember2020-12-310001037868ame:EuroOnePointThreeFourPercentSeniorNoteDueOctoberTwoThousandTwentySixMember2019-12-310001037868ame:SeniorNotesOnePointSevenOnePercentDueDecemberTwoThousendTwentySavenMember2020-12-310001037868ame:SeniorNotesOnePointSevenOnePercentDueDecemberTwoThousendTwentySavenMember2019-12-310001037868ame:EuroOnePointFiveThreePercentSeniorNoteDueOctoberTwoThousandTwentyEightMember2020-12-310001037868ame:EuroOnePointFiveThreePercentSeniorNoteDueOctoberTwoThousandTwentyEightMember2019-12-310001037868ame:SwissFrancTwoPointFourFourPercentSeniorNoteDueDecemberTwoThousandTwentyOneMember2011-12-310001037868ame:SwissFrancTwoPointFourFourPercentSeniorNoteDueDecemberTwoThousandTwentyOneMember2020-12-310001037868ame:SwissFrancTwoPointFourFourPercentSeniorNoteDueDecemberTwoThousandTwentyOneMember2019-12-310001037868ame:RevolvingCreditFacilityBorrowingsMember2020-12-310001037868ame:RevolvingCreditFacilityBorrowingsMember2019-12-310001037868ame:OtherPrincipallyForeignMember2020-12-310001037868ame:OtherPrincipallyForeignMember2019-12-31iso4217:GBP0001037868ame:SeniorNotesSixPointThreeZeroPercentDueDecemberTwoThousandNineteenMember2007-12-310001037868us-gaap:SeniorNotesMember2018-12-31iso4217:EUR0001037868us-gaap:SeniorNotesMember2018-01-012018-12-310001037868us-gaap:SeniorNotesMember2017-01-012017-12-310001037868us-gaap:SeniorNotesMember2019-01-012019-01-2100010378682014-09-300001037868ame:BritishPoundFourPointSixEightPercentSeniorNoteDueSeptemberTwoThousandTwentyMember2010-09-30iso4217:CHF0001037868ame:OnePointThreeFourPercentDueOctoberTwoThousandTwentySixMemberus-gaap:SeniorNotesMember2016-10-310001037868ame:OnePointThreeFourPercentDueOctoberTwoThousandTwentySixMemberus-gaap:SeniorNotesMember2020-12-3100010378682016-10-310001037868us-gaap:SeniorNotesMemberame:OnePointFiveThreePercentDueOctoberTwoThousandTwentyEightMember2020-12-310001037868ame:TwoPointFiveNinePercentDueNovemberTwoThousandTwentyEightMemberus-gaap:SeniorNotesMember2016-11-300001037868ame:TwoPointFiveNinePercentDueNovemberTwoThousandTwentyEightMemberus-gaap:SeniorNotesMember2020-12-310001037868us-gaap:SeniorNotesMemberame:TwoPointSevenZeroPercentDueNovemberTwoThousandThirtyOneMember2016-11-300001037868us-gaap:SeniorNotesMemberame:TwoPointSevenZeroPercentDueNovemberTwoThousandThirtyOneMember2020-12-310001037868us-gaap:RevolvingCreditFacilityMember2020-12-310001037868ame:AccordionFeatureMember2020-12-310001037868us-gaap:RevolvingCreditFacilityMember2019-12-310001037868us-gaap:LetterOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-12-310001037868us-gaap:LetterOfCreditMemberus-gaap:RevolvingCreditFacilityMember2019-12-310001037868ame:ForeignSubsidiariesMember2020-12-310001037868ame:ForeignSubsidiariesMember2019-12-310001037868us-gaap:ShareBasedCompensationAwardTrancheOneMember2020-01-012020-12-310001037868us-gaap:ShareBasedCompensationAwardTrancheTwoMember2020-01-012020-12-310001037868us-gaap:RestrictedStockMember2020-01-012020-12-310001037868us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001037868us-gaap:StockOptionMember2019-12-310001037868us-gaap:StockOptionMember2020-01-012020-12-310001037868us-gaap:StockOptionMember2020-12-310001037868ame:NonVestedStockOptionsMember2020-12-310001037868ame:NonVestedStockOptionsMember2020-01-012020-12-310001037868us-gaap:RestrictedStockMember2019-12-310001037868us-gaap:RestrictedStockMember2020-12-310001037868us-gaap:RestrictedStockMember2019-01-012019-12-310001037868us-gaap:RestrictedStockMember2018-01-012018-12-310001037868ame:OfficersAndKeyManagementEmployeesMemberame:PerformanceRestrictedStockUnitsMember2020-01-012020-03-310001037868srt:MinimumMemberame:OfficersAndKeyManagementEmployeesMemberame:PerformanceRestrictedStockUnitsMember2020-01-012020-03-310001037868ame:OfficersAndKeyManagementEmployeesMemberame:PerformanceRestrictedStockUnitsMembersrt:MaximumMember2020-01-012020-03-310001037868ame:PerformanceRestrictedStockUnitsMember2019-12-310001037868ame:PerformanceRestrictedStockUnitsMember2020-01-012020-12-310001037868ame:PerformanceRestrictedStockUnitsMember2020-12-310001037868ame:RestrictedStockGrantedPriorDateMember2020-01-012020-12-310001037868ame:NonEmployeeDirectorsRestrictedStockMember2020-01-012020-12-310001037868us-gaap:EmployeeStockOptionMemberame:ShareBasedPaymentArrangementTrancheFourMember2020-01-012020-12-310001037868us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2020-01-012020-12-310001037868us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2020-01-012020-12-310001037868us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2020-01-012020-12-310001037868us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2018-01-012018-01-010001037868us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2018-01-012018-01-010001037868us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2018-01-012018-01-010001037868us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:RestrictedStockMember2018-01-012018-01-010001037868us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:RestrictedStockMember2018-01-012018-01-010001037868us-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2018-01-012018-01-010001037868srt:MinimumMember2020-12-310001037868srt:MaximumMember2020-12-310001037868us-gaap:PensionPlansDefinedBenefitMembercountry:US2019-12-310001037868us-gaap:PensionPlansDefinedBenefitMembercountry:US2018-12-310001037868us-gaap:PensionPlansDefinedBenefitMembercountry:US2020-01-012020-12-310001037868us-gaap:PensionPlansDefinedBenefitMembercountry:US2019-01-012019-12-310001037868us-gaap:PensionPlansDefinedBenefitMembercountry:US2020-12-310001037868us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2019-12-310001037868us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2018-12-310001037868us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2020-01-012020-12-310001037868us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2019-01-012019-12-310001037868us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2020-12-310001037868ame:FundedPlansMembercountry:US2020-12-310001037868ame:FundedPlansMembercountry:US2019-12-310001037868ame:UnfundedPlansMembercountry:US2020-12-310001037868ame:UnfundedPlansMembercountry:US2019-12-310001037868country:US2020-12-310001037868country:US2019-12-310001037868ame:FundedPlansMemberus-gaap:ForeignPlanMember2020-12-310001037868ame:FundedPlansMemberus-gaap:ForeignPlanMember2019-12-310001037868ame:UnfundedPlansMemberus-gaap:ForeignPlanMember2020-12-310001037868ame:UnfundedPlansMemberus-gaap:ForeignPlanMember2019-12-310001037868us-gaap:ForeignPlanMember2020-12-310001037868us-gaap:ForeignPlanMember2019-12-310001037868country:US2020-01-012020-12-310001037868us-gaap:CorporateDebtSecuritiesMembercountry:US2020-12-310001037868us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMembercountry:US2020-12-310001037868us-gaap:CorporateDebtSecuritiesMembercountry:US2019-12-310001037868us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMembercountry:US2019-12-310001037868ame:CorporateDebtSecuritiesPreferredMembercountry:US2020-12-310001037868us-gaap:FairValueInputsLevel2Memberame:CorporateDebtSecuritiesPreferredMembercountry:US2020-12-310001037868ame:CorporateDebtSecuritiesPreferredMembercountry:US2019-12-310001037868us-gaap:FairValueInputsLevel2Memberame:CorporateDebtSecuritiesPreferredMembercountry:US2019-12-310001037868ame:CorporateCommonStockMembercountry:US2020-12-310001037868ame:CorporateCommonStockMemberus-gaap:FairValueInputsLevel1Membercountry:US2020-12-310001037868ame:CorporateCommonStockMembercountry:US2019-12-310001037868ame:CorporateCommonStockMemberus-gaap:FairValueInputsLevel1Membercountry:US2019-12-310001037868us-gaap:MunicipalBondsMembercountry:US2020-12-310001037868us-gaap:FairValueInputsLevel2Memberus-gaap:MunicipalBondsMembercountry:US2020-12-310001037868us-gaap:MunicipalBondsMembercountry:US2019-12-310001037868us-gaap:FairValueInputsLevel2Memberus-gaap:MunicipalBondsMembercountry:US2019-12-310001037868ame:RegisteredInvestmentCompaniesMembercountry:US2020-12-310001037868ame:RegisteredInvestmentCompaniesMemberus-gaap:FairValueInputsLevel1Membercountry:US2020-12-310001037868us-gaap:FairValueInputsLevel2Memberame:RegisteredInvestmentCompaniesMembercountry:US2020-12-310001037868ame:RegisteredInvestmentCompaniesMembercountry:US2019-12-310001037868ame:RegisteredInvestmentCompaniesMemberus-gaap:FairValueInputsLevel1Membercountry:US2019-12-310001037868ame:UsGovernmentSecuritiesMembercountry:US2020-12-310001037868ame:UsGovernmentSecuritiesMemberus-gaap:FairValueInputsLevel1Membercountry:US2020-12-310001037868us-gaap:FairValueInputsLevel2Memberame:UsGovernmentSecuritiesMembercountry:US2020-12-310001037868ame:UsGovernmentSecuritiesMembercountry:US2019-12-310001037868us-gaap:FairValueInputsLevel2Memberame:UsGovernmentSecuritiesMembercountry:US2019-12-310001037868us-gaap:DebtSecuritiesMembercountry:US2020-12-310001037868us-gaap:DebtSecuritiesMemberus-gaap:FairValueInputsLevel1Membercountry:US2020-12-310001037868us-gaap:FairValueInputsLevel2Memberus-gaap:DebtSecuritiesMembercountry:US2020-12-310001037868us-gaap:DebtSecuritiesMembercountry:US2019-12-310001037868us-gaap:DebtSecuritiesMemberus-gaap:FairValueInputsLevel1Membercountry:US2019-12-310001037868us-gaap:FairValueInputsLevel2Memberus-gaap:DebtSecuritiesMembercountry:US2019-12-310001037868ame:InvestmentsMeasuredAtNetAssetValueMembercountry:US2020-12-310001037868ame:InvestmentsMeasuredAtNetAssetValueMembercountry:US2019-12-310001037868country:US2020-12-310001037868us-gaap:FairValueInputsLevel1Membercountry:US2020-12-310001037868us-gaap:FairValueInputsLevel2Membercountry:US2020-12-310001037868country:US2019-12-310001037868us-gaap:FairValueInputsLevel1Membercountry:US2019-12-310001037868us-gaap:FairValueInputsLevel2Membercountry:US2019-12-310001037868country:US2019-01-012019-12-310001037868country:USus-gaap:EquitySecuritiesMember2020-12-310001037868us-gaap:FixedIncomeSecuritiesMembercountry:US2020-12-310001037868country:USame:CashAndOtherSecuritiesMember2020-12-310001037868us-gaap:ForeignPlanMember2020-01-012020-12-310001037868ame:LifeInsuranceMemberus-gaap:ForeignPlanMember2020-12-310001037868us-gaap:FairValueInputsLevel3Memberame:LifeInsuranceMemberus-gaap:ForeignPlanMember2020-12-310001037868ame:LifeInsuranceMemberus-gaap:ForeignPlanMember2019-12-310001037868us-gaap:FairValueInputsLevel3Memberame:LifeInsuranceMemberus-gaap:ForeignPlanMember2019-12-310001037868us-gaap:DebtSecuritiesMemberus-gaap:ForeignPlanMember2020-12-310001037868us-gaap:FairValueInputsLevel3Memberus-gaap:DebtSecuritiesMemberus-gaap:ForeignPlanMember2020-12-310001037868us-gaap:DebtSecuritiesMemberus-gaap:ForeignPlanMember2019-12-310001037868us-gaap:FairValueInputsLevel3Memberus-gaap:DebtSecuritiesMemberus-gaap:ForeignPlanMember2019-12-310001037868ame:InvestmentsMeasuredAtNetAssetValueMemberus-gaap:ForeignPlanMember2020-12-310001037868ame:InvestmentsMeasuredAtNetAssetValueMemberus-gaap:ForeignPlanMember2019-12-310001037868us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignPlanMember2020-12-310001037868us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignPlanMember2019-12-310001037868us-gaap:FairValueInputsLevel3Memberame:LifeInsuranceMemberus-gaap:ForeignPlanMember2018-12-310001037868us-gaap:FairValueInputsLevel3Memberame:LifeInsuranceMemberus-gaap:ForeignPlanMember2019-01-012019-12-310001037868us-gaap:FairValueInputsLevel3Memberame:LifeInsuranceMemberus-gaap:ForeignPlanMember2020-01-012020-12-310001037868us-gaap:ForeignPlanMemberus-gaap:EquitySecuritiesMember2020-12-310001037868us-gaap:FixedIncomeSecuritiesMemberus-gaap:ForeignPlanMember2020-12-310001037868ame:MultiAssetFundsMemberus-gaap:ForeignPlanMember2020-12-310001037868us-gaap:ForeignPlanMemberame:CashAndOtherSecuritiesMember2020-12-310001037868us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2020-12-310001037868us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2019-12-310001037868us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2020-12-310001037868us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2019-12-310001037868us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetTransitionAssetObligationMember2020-12-310001037868us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetTransitionAssetObligationMember2019-12-310001037868ame:NetPeriodicPensionBenefitExpenseMember2020-01-012020-12-310001037868country:US2018-01-012018-12-310001037868us-gaap:ForeignPlanMember2019-01-012019-12-310001037868us-gaap:ForeignPlanMember2018-01-012018-12-31ame:Site0001037868ame:HccMember2020-12-310001037868ame:HccMember2019-12-31ame:unit_Lawsuit0001037868us-gaap:LandMember2020-12-31ame:Segment0001037868us-gaap:OperatingSegmentsMemberame:ElectronicInstrumentsGroupMember2020-01-012020-12-310001037868us-gaap:OperatingSegmentsMemberame:ElectronicInstrumentsGroupMember2019-01-012019-12-310001037868us-gaap:OperatingSegmentsMemberame:ElectronicInstrumentsGroupMember2018-01-012018-12-310001037868ame:ElectromechanicalGroupMemberus-gaap:OperatingSegmentsMember2020-01-012020-12-310001037868ame:ElectromechanicalGroupMemberus-gaap:OperatingSegmentsMember2019-01-012019-12-310001037868ame:ElectromechanicalGroupMemberus-gaap:OperatingSegmentsMember2018-01-012018-12-310001037868us-gaap:OperatingSegmentsMember2020-01-012020-12-310001037868us-gaap:OperatingSegmentsMember2019-01-012019-12-310001037868us-gaap:OperatingSegmentsMember2018-01-012018-12-310001037868us-gaap:CorporateNonSegmentMember2020-01-012020-12-310001037868us-gaap:CorporateNonSegmentMember2019-01-012019-12-310001037868us-gaap:CorporateNonSegmentMember2018-01-012018-12-310001037868us-gaap:OperatingSegmentsMemberame:ElectronicInstrumentsGroupMember2020-12-310001037868us-gaap:OperatingSegmentsMemberame:ElectronicInstrumentsGroupMember2019-12-310001037868ame:ElectromechanicalGroupMemberus-gaap:OperatingSegmentsMember2020-12-310001037868ame:ElectromechanicalGroupMemberus-gaap:OperatingSegmentsMember2019-12-310001037868us-gaap:OperatingSegmentsMember2020-12-310001037868us-gaap:OperatingSegmentsMember2019-12-310001037868us-gaap:CorporateNonSegmentMember2020-12-310001037868us-gaap:CorporateNonSegmentMember2019-12-310001037868country:US2020-12-310001037868country:US2019-12-310001037868country:GB2020-12-310001037868country:GB2019-12-310001037868us-gaap:EuropeanUnionMember2020-12-310001037868us-gaap:EuropeanUnionMember2019-12-310001037868srt:AsiaMember2020-12-310001037868srt:AsiaMember2019-12-310001037868ame:OtherForeignCountriesMember2020-12-310001037868ame:OtherForeignCountriesMember2019-12-310001037868ame:InternationalMember2020-12-310001037868ame:InternationalMember2019-12-3100010378682019-02-1200010378682020-02-1200010378682020-02-122020-02-1200010378682019-10-012019-12-310001037868us-gaap:SubsequentEventMember2021-02-110001037868us-gaap:SubsequentEventMember2021-02-112021-02-1100010378682020-10-012020-12-310001037868ame:ReductionInWorkspaceMember2020-01-012020-12-310001037868us-gaap:CostOfSalesMemberame:ReductionInWorkspaceMember2020-01-012020-12-310001037868ame:ReductionInWorkspaceMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310001037868ame:ReductionInWorkspaceMemberus-gaap:OperatingSegmentsMemberame:ElectronicInstrumentsGroupMember2020-01-012020-12-310001037868ame:ElectromechanicalGroupMemberame:ReductionInWorkspaceMemberus-gaap:OperatingSegmentsMember2020-01-012020-12-31
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
FORM 10-K
_____________________
(Mark One)
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2020
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to 
Commission File Number 1-12981
_____________________
AMETEK, Inc.
(Exact name of registrant as specified in its charter)
_____________________
Delaware
(State or other jurisdiction of
incorporation or organization)
1100 Cassatt Road
Berwyn, Pennsylvania
(Address of principal executive offices)
14-1682544
(I.R.S. Employer
Identification No.)
19312-1177
(Zip Code)
Registrant’s telephone number, including area code: (610) 647-2121
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Common Stock, $0.01 Par Value (voting)
Trading symbol(s)
AME
Name of each exchange on which registered
New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
_____________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes  No
The aggregate market value of the voting stock held by non-affiliates of the registrant was approximately $20.5 billion as of June 30, 2020, the last business day of the registrant’s most recently completed second fiscal quarter.
The number of shares of the registrant’s Common Stock outstanding as of January 29, 2021 was 230,563,891.
Documents Incorporated by Reference
Part III incorporates information by reference from the Proxy Statement for the Annual Meeting of Stockholders on May 6, 2021.


Table of Contents
AMETEK, Inc.
2020 Form 10-K Annual Report
Table of Contents
Page
1

Table of Contents
PART I
Item 1.    Business
General Development of Business
AMETEK, Inc. (“AMETEK” or the “Company”) is incorporated in Delaware. Its predecessor was originally incorporated in Delaware in 1930 under the name American Machine and Metals, Inc. AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices with operations in North America, Europe, Asia and South America. AMETEK maintains its principal executive offices in suburban Philadelphia at 1100 Cassatt Road, Berwyn, Pennsylvania, 19312. Listed on the New York Stock Exchange (symbol: AME), the common stock of AMETEK is a component of the Standard and Poor’s 500 and the Russell 1000 Indices.
Products and Services
AMETEK’s products are marketed and sold worldwide through two operating groups: Electronic Instruments (“EIG”) and Electromechanical (“EMG”). Electronic Instruments is a leader in the design and manufacture of advanced instruments for the process, power and industrial, and aerospace markets. Electromechanical is a differentiated supplier of precision motion control solutions, thermal management systems, specialty metals and electrical interconnects. Its end markets include aerospace and defense, medical, automation and other industrial markets.
Competitive Strengths
Management believes AMETEK has significant competitive advantages that help strengthen and sustain its market positions. Those advantages include:
Significant Market Share.    AMETEK maintains significant market share in a number of targeted niche markets through its ability to produce and deliver high-quality, differentiated products at competitive prices. EIG has significant market positions in niche segments of the process, power and industrial, and aerospace markets. EMG holds significant positions in niche segments of the aerospace and defense, automation and medical markets.
Technological and Development Capabilities.    AMETEK believes it has certain technological advantages over its competitors that allow it to maintain its leading market positions. Historically, it has demonstrated an ability to develop innovative new products and solutions that anticipate customer needs. It has consistently added to its investment in research, development and engineering, and improved its new product development efforts with the adoption of Design for Six Sigma and Value Analysis/Value Engineering methodologies. These have improved the pace and quality of product innovation and resulted in the introduction of a steady stream of new products across all of AMETEK’s businesses.
Efficient and Flexible Manufacturing Operations.    Through its Operational Excellence initiatives, AMETEK has established a lean and flexible manufacturing platform for its businesses. In its effort to achieve best-cost manufacturing, AMETEK had plants, as of December 31, 2020, in Brazil, China, the Czech Republic, Malaysia, Mexico, and Serbia. These plants offer proximity to customers and provide opportunities for increasing international sales. Acquisitions also have allowed AMETEK to achieve operating synergies by consolidating operations, product lines and distribution channels, benefiting both of AMETEK’s operating groups.
Experienced Management Team.    Another component of AMETEK’s success is the strength of its management team and that team’s commitment to improving Company performance. AMETEK senior management has extensive industry experience and an average of approximately 28 years of AMETEK service. The management team is focused on delivering strong, consistent and profitable growth, and growing


Table of Contents
shareholder value. Individual performance is tied to financial results through Company-established stock ownership guidelines and equity incentive programs.
Business Strategy
AMETEK is committed to achieving earnings growth through the successful implementation of the AMETEK Growth Model. The goal of that model is double-digit annual percentage growth in sales and earnings per share over the business cycle and a superior return on total capital. Other financial initiatives have been or may be undertaken, including public and private debt or equity issuance, bank debt refinancing, local financing in certain foreign countries and share repurchases.
AMETEK’s Growth Model integrates the four growth strategies of Operational Excellence, Strategic Acquisitions, Global and Market Expansion, and New Product Development with a focus on cash generation and capital deployment.
Operational Excellence.    Operational Excellence is AMETEK’s cornerstone strategy for accelerating growth, improving profit margins and strengthening its competitive position across its businesses. Operational Excellence focuses on initiatives to drive increased organic sales growth, improvements in operating efficiencies and sustainable practices. It emphasizes team building and a participative management culture. AMETEK’s Operational Excellence strategies include lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis and growth kaizens. Each plays an important role in improving efficiency, enhancing the pace and quality of innovation and driving profitable sales growth. Operational Excellence initiatives have yielded lower operating and administrative costs, shortened manufacturing cycle times, resulted in higher cash flow from operations and increased customer satisfaction. They also have played a key role in achieving synergies from newly acquired companies.
Strategic Acquisitions.    Acquisitions are a key to achieving the goals of the AMETEK Growth Model. Since the beginning of 2016 through December 31, 2020, AMETEK has completed 17 acquisitions with annualized sales totaling approximately $1.0 billion, including one acquisition in 2020. AMETEK targets companies that offer compelling strategic, technical and cultural fit. It seeks to acquire businesses in adjacent markets with complementary products and technologies. It also looks for businesses that provide attractive growth opportunities, often in new and emerging markets. Through these and prior acquisitions, AMETEK’s management team has developed considerable skill in identifying, acquiring and integrating new businesses. As it has executed its acquisition strategy, AMETEK’s mix of businesses has shifted toward those that are more highly differentiated and, therefore, offer better opportunities for growth and profitability.
Global & Market Expansion.    AMETEK has historically experienced growth outside the United States, reflecting an expanding international customer base, investments in its global infrastructure and the attractive growth potential of its businesses in overseas markets. While Europe remains its largest overseas market, AMETEK has pursued growth opportunities worldwide, especially in key emerging markets. It has grown sales in Latin America and Asia by strategically building, acquiring and expanding manufacturing facilities. AMETEK also has expanded its sales, service, and engineering capabilities globally. Recently acquired businesses have further added to AMETEK’s international presence.
New Products.    New products are essential to AMETEK’s long-term growth. As a result, AMETEK has maintained a consistent investment in new product development and engineering. AMETEK's businesses help solve our customers' most complex challenges with differentiated technology solutions. In 2020, AMETEK added to its highly differentiated product portfolio with a range of new products across many of its businesses.
AMETEK focuses on cash generation and capital deployment  AMETEK generates strong cash flow given its asset-light business model and strong operational execution. This cash flow supports AMETEK’s capital deployment strategy with its primary focus on strategic, value-enhancing acquisitions. We are committed to paying a modest quarterly dividend.
3

Table of Contents
Description of Business
Described below are the products and markets of each reportable segment:
EIG
EIG is a leader in the design and manufacture of advanced analytical, test and measurement instruments for the process, aerospace, medical, research, power and industrial markets. Its growth is based on the strategies outlined in the AMETEK Growth Model. In many instances, its products differ from or are technologically superior to its competitors’ products. It has achieved competitive advantage through continued investment in research, development and engineering to develop market-leading products and solutions that serve niche markets. It also has expanded its sales and service capabilities globally to serve its customers.
EIG is a leader in many of the specialized markets it serves. Products supplied to these markets include process control instruments for the life sciences, pharmaceutical, semiconductor, automation, food and beverage, oil and gas, and petrochemical industries. It provides a growing range of instruments to the research and laboratory equipment, ultra precision manufacturing, medical, and test and measurement markets. It is a leader in power quality monitoring and metering, uninterruptible power systems, programmable power equipment, electromagnetic compatibility (“EMC”) test equipment, sensors for gas turbines, dashboard instruments for heavy trucks, and instrumentation and controls for the food and beverage industries. It supplies the aerospace industry with aircraft and engine sensors, monitoring systems, power supplies, fuel and fluid measurement systems, and data acquisition systems.
In 2020, 49% of EIG’s net sales were to customers outside the United States. At December 31, 2020, EIG employed approximately 9,300 people, of whom approximately 900 were covered by collective bargaining agreements. At December 31, 2020, EIG had operating facilities in the United States, the United Kingdom, Germany, Canada, China, Denmark, Finland, France, Switzerland, Argentina, Austria and Mexico. EIG also shares operating facilities with EMG in Brazil, China and Mexico.
Process and Analytical Instrumentation Markets and Products
Process and analytical instrumentation sales represented 73% of EIG’s 2020 net sales. These businesses include process analyzers, emission monitors and spectrometers; elemental and surface analysis instruments; level, pressure and temperature sensors and transmitters; radiation measurement devices; level measurement devices; precision manufacturing systems; materials- and force-testing instruments; contact and non-contact metrology products; and clinical and educational communication solutions. Among the industries it serves are power generation; pharmaceutical manufacturing; medical and healthcare; water and waste treatment; semiconductor manufacturing; natural gas distribution; and oil, gas, and petrochemical refining. Its instruments are used for precision measurement in a number of applications, including radiation detection, trace element and materials analysis, nanotechnology research, ultraprecise manufacturing, and test and measurement.
Acquired in October 2019, Gatan is a leading manufacturer of instrumentation and software used to enhance and extend the operation and performance of electron microscopes. Gatan’s differentiated technology solutions, premier brand and leadership positions in growth markets complements the Company’s existing portfolio of specialized offerings in high-end analytical instrumentation.
Aerospace and Power Instrumentation Markets and Products
Aerospace and Power Instrumentation sales represented 27% of EIG’s 2020 net sales. These businesses produce a wide array of instrumentation, systems and sensors for applications in the aerospace, power and industrial markets.
These businesses produce power monitoring and metering instruments, uninterruptible power supply systems and programmable power supplies used in a wide range of industrial settings. It is a leader in the design and
4

Table of Contents
manufacture of power measurement, quality monitoring and event recorders for use in power generation, transmission and distribution. It provides uninterruptible power supply systems, multifunction electric meters, annunciators, alarm monitoring systems and highly specialized communications equipment for smart grid applications. It also offers precision power supplies and power conditioning products, and electrical immunity and EMC test equipment, sensors for gas turbines, dashboard instruments for heavy trucks and other vehicles, and instrumentation and controls for the food and beverage industries.
AMETEK’s aerospace products are designed to customer specifications and manufactured to stringent operational and reliability requirements. These products include airborne data systems, turbine engine temperature measurement products, vibration-monitoring systems, cockpit instruments and displays, fuel and fluid measurement products, and sensors and switches. AMETEK serves all segments of the commercial and military aerospace market, including commercial airliners, business jets, regional aircraft and helicopters.
AMETEK operates in highly specialized aerospace market segments in which it has proven technological or manufacturing advantages versus its competition. Among its more significant competitive advantages is its 70-year-plus reputation as an established aerospace supplier. It has long-standing relationships with the world’s leading commercial and military aircraft, jet engine and original equipment manufacturers and aerospace system integrators. AMETEK also is a leading provider of spare part sales, repairs and overhaul services to commercial aerospace.
Acquired in January 2020, IntelliPower is a leading provider of high-reliability, ruggedized uninterruptible power systems serving a wide range of defense and industrial applications.
Customers
EIG is not dependent on any single customer such that the loss of that customer would have a material adverse effect on EIG’s operations. Approximately 7% of EIG’s 2020 net sales were made to its five largest customers. No single customer comprises more than 5% of net sales.
EMG
EMG is a differentiated supplier of automation solutions, thermal management systems, specialty metals and electrical interconnects. EMG is a leader in many of the niche markets in which it competes. Products supplied to these markets include its advanced precision motion control solutions, which are used in a wide range of automation applications across the medical, semiconductor, aerospace, defense, and food and beverage industries, as well as its highly engineered electrical connectors and electronics packaging used in aerospace and defense, medical, and industrial applications.
EMG supplies high-purity powdered metals, strip and foil, specialty clad metals and metal matrix composites. Its blowers and heat exchangers provide electronic cooling and environmental control for the aerospace and defense industries. Its motors are widely used in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps and industrial blowers. Additionally, it operates a global network of aviation maintenance, repair and overhaul (“MRO”) facilities.
EMG designs and manufactures products that, in many instances, are significantly different from or technologically superior to competitors’ products. It has achieved competitive advantage through continued investment in research, development and engineering, efficiency improvements from operational excellence, acquisition synergies and improved supply chain management.
In 2020, 47% of EMG’s net sales were to customers outside the United States. At December 31, 2020, EMG employed approximately 6,900 people, of whom approximately 1,700 were covered by collective bargaining agreements. At December 31, 2020, EMG had operating facilities in the United States, the United Kingdom, China, Germany, France, Italy, Mexico, Serbia, Brazil, the Czech Republic, Malaysia and Taiwan.

5

Table of Contents
Automation and Engineered Solutions Markets and Products
Automation and Engineered Solution sales represented 70% of EMG’s 2020 net sales. These businesses produce precision motion control solutions, brushless motors, blowers and pumps, heat exchangers and other electromechanical systems. These products are used in a wide variety of automation applications, semiconductor equipment, medical equipment and power industries among others. Additionally, these businesses produce specialty motors which are used in a wide range of products, such as household, commercial and personal care appliances, fitness equipment, food and beverage machines, hydraulic pumps and industrial blowers.
AMETEK is a leader in highly engineered electrical connectors and electronics packaging used to protect sensitive devices and mission-critical electronics. Its electrical connectors, terminals, headers and packaging are designed specifically for harsh environments and highly customized applications. In addition, AMETEK is an innovator and market leader in specialized metal powder, strip, wire and bonded products used in medical, aerospace and defense, telecommunications, automotive and general industrial applications.
Aerospace Markets and Products
Aerospace sales represented 30% of EMG’s 2020 net sales. These businesses produce motor-blower systems and heat exchangers used in thermal management and other applications on a variety of military and commercial aircraft and military ground vehicles. In addition, these businesses provide the commercial and military aerospace industry with third-party MRO services on a global basis with facilities in the United States, Europe and Asia.
Acquired in September 2019, Pacific Design Technologies, Inc. ("PDT") designs and manufactures a complete range of custom-engineered, liquid cooling systems and components used in a broad set of current and next-generation commercial aerospace, defense and space platforms. PDT enhances the Company’s position in the aerospace and defense sectors with its innovative technology and differentiated solutions in thermal management systems.
Customers
EMG is not dependent on any single customer such that the loss of that customer would have a material adverse effect on EMG’s operations. Approximately 10% of EMG’s 2020 net sales were made to its five largest customers. No single customer comprises greater than 5% of net sales.
Marketing
AMETEK’s marketing efforts generally are organized and carried out at the business level. EIG makes use of distributors and sales representatives to market its products along with a direct sales force for its technically sophisticated products. Within aerospace, the specialized customer base of aircraft and jet engine manufacturers is served primarily by direct sales engineers. Given the technical nature of its many products, as well as its significant worldwide market share, EMG conducts much of its domestic and international marketing activities through a direct sales force and makes some use of sales representatives and distributors, both in the United States and in other countries.
Competition
In general, AMETEK’s markets are highly competitive with competition based on technology, performance, quality, service and price.
In EIG’s markets, AMETEK believes it ranks as a leader in certain analytical measurement and control instruments, and power and industrial markets. It also is a major instrument and sensor supplier to commercial aviation. In process and analytical instruments, numerous companies compete in each market on the basis of product quality, performance and innovation. In power and industrial and in aerospace, AMETEK competes with a number of companies depending on the specific market segment.
6

Table of Contents
EMG’s businesses compete with a number of companies in each of its markets. Competition is generally based on product innovation, performance and price. There also is competition from alternative materials and processes.
Availability of Raw Materials
AMETEK’s reportable segments obtain raw materials and supplies from a variety of sources and generally from more than one supplier. For EMG, however, certain items, including various base metals and certain steel components, are available from only a limited number of suppliers. AMETEK believes its sources and supplies of raw materials are adequate for its needs.
Environmental and Other Governmental Regulation
AMETEK's operations and properties are subject to laws and regulations relating to environmental protection, including those governing air emissions, water discharges, waste management and workplace safety. The Company uses, generates and disposes of hazardous substances and waste in its operations and could be subject to material liabilities relating to the investigation and clean-up of contaminated properties and related claims. The Company is required to conform our operations and properties to these laws and adapt to regulatory requirements in all countries as these requirements change. In connection with acquisitions, the Company will assess potential material environmental liabilities, and determine regulatory and fiduciary obligations during the course of the due diligence process. In addition, new laws and regulations, the discovery of previously unknown contamination or the imposition of new requirements could increase our costs or subject us to new or increased liabilities.
Information with respect to environmental matters is set forth in Note 13 to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
Patents, Licenses and Trademarks
AMETEK owns numerous unexpired U.S. and foreign patents, including counterparts of its more important U.S. patents, in the major industrial countries of the world. It is a licensor or licensee under patent agreements of various types, and its products are marketed under various registered and unregistered U.S. and foreign trademarks and trade names. AMETEK, however, does not consider any single patent or trademark, or any group of them, essential either to its business as a whole or to either one of its reportable segments. The annual royalties received or paid under license agreements are not significant to either of its reportable segments or to AMETEK’s overall operations.
Human Capital Management
As a global organization, AMETEK has seen firsthand that the innovation needed to solve our customers’ biggest challenges can only come from employees that are fully engaged, committed, and have diverse perspectives and backgrounds. Our Board regularly receives updates and presentations on key culture topics, including environmental, social and governance compliance, diversity and inclusion, and employee development and succession.
Our executive management team reviews the key talent across our company annually and assesses the adequacy of talent to meet business challenges and future growth needs. A major area of focus is a review of diversity and inclusion improvement efforts. We have a Women’s Business Council and an African American Business Council, both of which drive initiatives focused on mentorship, education, and career guidance. Diverse candidate slates are required for external salaried openings, including executive management and Board appointments, where at least one diverse candidate is interviewed.

7

Table of Contents
We have a longstanding commitment to responsible corporate conduct. Each employee is provided with annual performance goals which are reviewed in a performance review with their manager. Employee feedback is actively encouraged through an open-door policy for all managers, regular town hall/all hands meetings, executive presentations with Q&A sessions, a regular CEO podcast for all employees, and a Hotline that can be used to report complaints.
Additionally, we strive to protect health and safety in every aspect of our enterprise – from the way we design, manufacture, and deliver our products to the way our customers use them. We continue to drive towards our goal of zero lost-time work incidents. Our 2020 lost-time incident rate was the lowest ever and we continue to enhance our safety initiatives as each facility is tasked with identifying opportunities for additional safety measures. Businesses with zero incidents share best practices and ensure ongoing training to maintain their safety excellence. In addition to our Environmental Health, and Safety facility audits, our facilities’ activities include safety committees, continual training, documented self-audits, and behavior-based safety observations and feedback.
At December 31, 2020, AMETEK employed approximately 16,500 people at its EIG, EMG and corporate operations, of whom approximately 2,600 employees were covered by collective bargaining agreements.
Available Information
AMETEK’s annual report on Form  10-K, quarterly reports on Form  10-Q, current reports on Form  8-K and all amendments to those reports filed or furnished pursuant to Section 13(a) of the Securities Exchange Act of 1934 are made available free of charge on the Company’s website at www.ametek.com in the “Investors – Financial Information” section as soon as reasonably practicable after such material is electronically filed with, or furnished to, the U.S. Securities and Exchange Commission. All reports filed with the Securities Exchange Commission can also be viewed on their website at www.sec.gov. AMETEK has posted in the “Investors – Governance” section of its website its corporate governance guidelines, Board committee charters, codes of ethics, and social and environmental policies. Those documents also are available free of charge in published form to any stockholder who requests them by writing to the Investor Relations Department at AMETEK, Inc., 1100 Cassatt Road, Berwyn, Pennsylvania, 19312.
Item 1A.    Risk Factors
You should consider carefully the following risk factors and all other information contained in this Annual Report on Form 10-K and the documents we incorporate by reference in this Annual Report on Form 10-K. Any of the following risks could materially and adversely affect our business, financial condition, results of operations and cash flows.
Risks Related to Our Operations
The coronavirus global pandemic could have a material adverse effect on our ability to operate, results of operations, financial condition, liquidity and ability to consummate future acquisitions.
In March 2020, the World Health Organization declared the COVID-19 outbreak to be a global pandemic. The outbreak of COVID-19, and any other significant outbreak of epidemic, pandemic or contagious disease, could have a negative effect on our ability to operate, results of operations, financial condition, liquidity and ability to consummate future acquisitions. In addition, the outbreak of COVID-19 has resulted in a widespread health crisis that is adversely affecting the economies and financial markets of many countries and the end markets for many of our products, which could result in an economic downturn that may negatively affect demand for our products. The extent to which COVID-19 will impact our business, results of operations and financial condition is highly uncertain and will depend on future developments. Such developments may include the geographic spread and duration of the virus, the severity of the disease and the actions that may be taken by various governmental authorities and other third parties in response to the outbreak.
8

Table of Contents
Our global manufacturing facilities remain open with a focus on safety protocols, though a range of external factors related to the pandemic that are not within our control have restricted our ability to keep our manufacturing facilities fully operational. Additionally, while our global supply chains are currently not materially affected, it is unknown whether and to what extent they may be affected if the COVID-19 pandemic persists for an extended period. Any decline or lower than expected demand in our served markets could diminish demand for our products and services, which would adversely affect our financial condition and results of operations. Moreover, the COVID-19 pandemic may adversely affect the financial condition of our customers and suppliers in the future or their ability to purchase Company products, may delay customers’ purchasing decisions, result in a shift to lower-priced products or away from discretionary products, and may result in longer payment terms or inability to collect customer payments. These issues may also materially affect our future access to our sources of liquidity, particularly our cash flows from operations, financial condition and ability to consummate future acquisitions.
In compliance with stay-at-home orders issued in connection with the COVID-19 pandemic, a significant subset of our employees have transitioned to working from home. As a result, more of our employees are working from locations where our cybersecurity program may be less effective and IT security may be less robust. This change may create increased vulnerability to cybersecurity incidents, including breaches of information systems security, which could result in a disruption of our operations, customer dissatisfaction, damage to our reputation and a loss of customers or revenues.
If significant portions of our workforce are unable to work effectively, including because of illness, quarantines or absenteeism; government actions; facility closures; work slowdowns or stoppages; limited supplies or resources; or other circumstances related to COVID-19, our operations will be further impacted. We may be unable to perform fully on our customer obligations and we may incur liabilities and suffer losses as a result. The continued spread of COVID-19 may also affect our ability to hire, develop and retain our talented and diverse workforce, and our ability in short periods to fully maintain and support our corporate culture.
A scarcity of resources or other hardships caused by the COVID-19 pandemic may result in increased nationalism, protectionism and political tensions which may cause governments and/or other entities to take actions that may have significant negative impact on the Company, its suppliers, and its customers to conduct business in the future. Risks related to consumers and businesses lowering or changing spending, which impact domestic and cross-border spend, are described in our risk factor titled “Foreign and domestic economic, political, legal, compliance and business factors could negatively affect our international sales and operations”.
The duration and intensity of the impact of the COVID-19 pandemic and the resulting disruption to our operations is uncertain but could have a material impact on our operations, cash flows, financial condition and ability to consummate future acquisitions. We will continue to assess the financial impact of the pandemic on our business.
A downturn in the economy generally or in the markets we serve could adversely affect our business.
A number of the industries in which we operate are cyclical in nature and therefore are affected by factors beyond our control. A downturn in the U.S. or global economy, and, in particular, in the aerospace and defense, oil and gas, process instrumentation or power markets could have an adverse effect on our business, financial condition and results of operations.
Our growth could suffer if the markets into which we sell our products and services decline, do not grow as anticipated or experience cyclicality.
Our growth depends in part on the growth of the markets which we serve. Visibility into the future performance of certain of our markets is limited (particularly for markets into which we sell through distribution). Our quarterly sales and profits depend substantially on the volume and timing of orders received during the fiscal quarter, which are difficult to forecast. Any decline or lower than expected growth in our served markets could diminish demand for our products and services, which would adversely affect our financial statements. A number of our businesses operate in industries that may experience periodic, cyclical downturns. In addition, in certain of our
9

Table of Contents
businesses, demand depends on customers’ capital spending budgets, as well as government funding policies. Matters of public policy and government budget dynamics, as well as product and economic cycles, can affect the spending decisions of these customers. Demand for our products and services is also sensitive to changes in customer order patterns, which may be affected by announced price changes, changes in incentive programs, new product introductions and customer inventory levels. Any of these factors could adversely affect our growth and results of operations in any given period.
We may not properly execute, or realize anticipated cost savings or benefits from, our Operational Excellence initiatives.
Our success is partly dependent upon properly executing and realizing cost savings or other benefits from our ongoing production and procurement initiatives. These initiatives are primarily designed to make the Company more efficient, which is necessary in the Company’s highly competitive industries. These initiatives are often complex, and a failure to implement them properly may, in addition to not meeting projected cost savings or benefits, adversely affect our business and operations.
Foreign and domestic economic, political, legal, compliance and business factors could negatively affect our international sales and operations.
International sales for 2020 and 2019 represented 48.7% and 48.0% of our consolidated net sales, respectively. As a result of our growth strategy, we anticipate that the percentage of sales outside the United States will increase in the future. As of December 31, 2020, we have manufacturing operations in 17 countries outside the United States, with significant operations in China, the Czech Republic, Germany, Mexico, Serbia and the United Kingdom. A disruption of our ability to obtain a supply of goods from these countries or a change in the cost to purchase, manufacture, or distribute these products could have an adverse effect on our sales and operations. International sales and operations are subject to the customary risks of operating in an international environment, including:
Imposition of trade or foreign exchange restrictions, including in the United States;
Overlap of different tax structures;
Unexpected changes in regulatory requirements, including in the United States;
Trade protection measures, such as the imposition of or increase in tariffs and other trade barriers, including in the United States;
The difficulty and/or costs of designing and implementing an effective control environment across diverse regions and employee bases;
Restrictions on currency repatriation;
General economic conditions;
Unstable political situations and social unrest, both internationally and in the United States;
Nationalization of assets; and
Compliance with a wide variety of international and U.S. laws and regulatory requirements.
Furthermore, fluctuations in foreign currency exchange rates, including changes in the relative value of currencies in the countries where we operate, subject us to exchange rate exposure and may adversely affect our financial statements. For example, increased strength in the U.S. dollar will increase the effective price of our products sold overseas, which may adversely affect sales or require us to lower our prices. In addition, our
10

Table of Contents
consolidated financial statements are presented in U.S. dollars, and we must translate our assets, liabilities, sales and expenses into U.S. dollars for external reporting purposes. As a result, changes in the value of the U.S. dollar due to fluctuations in currency exchange rates or currency exchange controls may materially and negatively affect the value of these items in our consolidated financial statements, even if their value has not changed in their local currency.
Our international sales and operations may be adversely impacted by compliance with export laws.
We are required to comply with various import, export, export control and economic sanctions laws, which may affect our transactions with certain customers, business partners and other persons, including in certain cases dealings with or between our employees and subsidiaries. In certain circumstances, export control and economic sanctions regulations may prohibit the export of certain products, services and technologies and in other circumstances, we may be required to obtain an export license before exporting a controlled item. In addition, failure to comply with any of these regulations could result in civil and criminal, monetary and non-monetary penalties, disruptions to our business, limitations on our ability to import and export products and services and damage to our reputation.
Our reputation, ability to do business and financial statements may be impaired by improper conduct by any of our employees, agents or business partners.
We cannot provide assurance that our internal controls and compliance systems will always protect us from acts committed by employees, agents or business partners of ours (or of businesses we acquire or partner with) that would violate U.S. and/or non-U.S. laws, including the laws governing payments to government officials, bribery, fraud, kickbacks and false claims, pricing, sales and marketing practices, conflicts of interest, competition, export and import compliance, money laundering and data privacy. In particular, the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and similar anti-bribery laws in other jurisdictions generally prohibit companies and their intermediaries from making improper payments to government officials for the purpose of obtaining or retaining business, and we operate in many parts of the world that have experienced governmental corruption to some degree. Any such improper actions or allegations of such acts could damage our reputation and subject us to civil or criminal investigations in the U.S. and in other jurisdictions and related shareholder lawsuits could lead to substantial civil and criminal, monetary and non-monetary penalties and could cause us to incur significant legal and investigatory fees. In addition, we rely on our suppliers to adhere to our supplier standards of conduct and violations of such standards of conduct could occur that could have a material effect on our financial statements.
Any inability to hire, train and retain a sufficient number of skilled officers and other employees could impede our ability to compete successfully.
If we cannot hire, train and retain a sufficient number of qualified employees, we may not be able to effectively integrate acquired businesses and realize anticipated results from those businesses, manage our expanding international operations and otherwise profitably grow our business. Even if we do hire and retain a sufficient number of employees, the expense necessary to attract and motivate these officers and employees may adversely affect our results of operations.
If we are unable to develop new products on a timely basis, it could adversely affect our business and prospects.
We believe that our future success depends, in part, on our ability to develop, on a timely basis, technologically advanced products that meet or exceed appropriate industry standards. Maintaining our existing technological advantages will require us to continue investing in research and development and sales and marketing. There can be no assurance that we will have sufficient resources to make such investments, that we will be able to make the technological advances necessary to maintain such competitive advantages or that we can recover major research and development expenses. We are not currently aware of any emerging standards or new products which could render our existing products obsolete, although there can be no assurance that this will not occur or that we will be able to develop and successfully market new products.

11

Table of Contents
Our technology is important to our success and our failure to protect this technology could put us at a competitive disadvantage.
Many of our products rely on proprietary technology; therefore, we endeavor to protect our intellectual property rights through patents, copyrights, trade secrets, trademarks, confidentiality agreements and other contractual provisions. Despite our efforts to protect proprietary rights, unauthorized parties or competitors may copy or otherwise obtain and use our products or technology. In addition, our ability to protect and enforce our intellectual property rights may be limited in certain countries outside the U.S. Actions to enforce our rights may result in substantial costs and diversion of resources and we make no assurances that any such actions will be successful.
A disruption in, shortage of, or price increases for, supply of our components and raw materials may adversely impact our operations.
While we manufacture certain parts and components used in our products, we require substantial amounts of raw materials and purchase some parts and components from suppliers. The availability and prices for raw materials, parts and components may be subject to curtailment or change due to, among other things, supplier’s allocation to other purchasers, interruptions in production by suppliers, changes in exchange rates and prevailing price levels. In addition, our facilities, supply chains, distribution systems, and products may be impacted by natural or man-made disruptions, including armed conflict, damaging weather or other acts of nature, pandemics or other public health crises. A shutdown of, or inability to utilize, one or more of our facilities, our supply chain, or our distribution system could significantly disrupt our operations, delay production and shipments, our relationships and reputation with customers, suppliers, employees, stockholders and others, result in lost sales, result in the misappropriation or corruption of data, or result in legal exposure and large remediation or other expenses. Furthermore, certain items, including base metals and certain steel components, are available only from a limited number of suppliers and are subject to commodity market fluctuations. Shortages in raw materials or price increases therefore could affect the prices we charge, our operating costs and our competitive position, which could adversely affect our business, financial condition, results of operations and cash flows.
We are subject to numerous governmental regulations, which may be burdensome or lead to significant costs.
Our operations are subject to numerous federal, state, local and foreign governmental laws and regulations. In addition, existing laws and regulations may be revised or reinterpreted and new laws and regulations, including with respect to privacy legislation and climate change, may be adopted or become applicable to us or customers for our products. For example, we are subject to federal, state and international privacy laws relating to the collection, use, retention, security and transfer of personally identifiable information. In many cases, these laws apply not only to third-party transactions, but also to transfers of information between the Company and its subsidiaries, and among the Company, its subsidiaries and other parties with which the Company has commercial relations. Several jurisdictions have passed laws in this area, and other jurisdictions are considering imposing additional restrictions. These laws continue to develop and may be inconsistent from jurisdiction to jurisdiction. Complying with emerging and changing international requirements may cause the Company to incur substantial costs or require the Company to change its business practices. We cannot predict the form any such new laws or regulations will take or the impact any of these laws and regulations will have on our business or operations.
We operate in highly competitive industries, which may adversely affect our results of operations or ability to expand our business.
Our markets are highly competitive. We compete, domestically and internationally, with individual producers, as well as with vertically integrated manufacturers, some of which have resources greater than we do. The principal elements of competition for our products are product technology, quality, service, distribution and price. Although we believe EIG is a market leader, competition is strong and could intensify in the markets served by EIG. In the aerospace markets served by EIG, a limited number of companies compete on the basis of product quality, performance and innovation. EMG’s competition in specialty metal products stems from alternative materials and processes. Our competitors may develop new or improve existing products that are superior to our
12

Table of Contents
products or may adapt more readily to new technologies or changing requirements of our customers. There can be no assurance that our business will not be adversely affected by increased competition in the markets in which it operates or that our products will be able to compete successfully with those of our competitors.
Our business and financial performance could be adversely impacted by a significant disruption in, or breach in security of, our information technology systems.
We rely on information technology systems, some of which are managed by third-parties, to process, transmit and store electronic information (including sensitive data such as confidential business information and personally identifiable data relating to employees, customers, other business partners and patients), and to manage or support a variety of critical business processes and activities (such as receiving and fulfilling orders, billing, collecting and making payments, shipping products, providing services and support to customers and fulfilling contractual obligations). These systems, products and services may be damaged, disrupted or shut down due to attacks by computer hackers, computer viruses, ransomware, human error or malfeasance, power outages, hardware failures, telecommunication or utility failures, catastrophes or other unforeseen events. In any such circumstances our system redundancy and other disaster recovery planning may be ineffective or inadequate. Further, given a significant subset of our employees have transitioned to working from home, disaster recovery may take longer to complete.
Attacks may also target hardware, software and information installed, stored or transmitted in our products after such products have been purchased and incorporated into third-party products, facilities or infrastructure. Like most multinational corporations, our information technology systems have been subject to computer viruses, malicious codes, unauthorized access and other cyber-attacks and we expect the sophistication and frequency of such attacks to continue to increase. Any of the attacks, breaches or other disruptions or damage described above could interrupt our operations or the operations of our customers and partners, delay production and shipments, result in theft of intellectual property and trade secrets, damage customer and business partner relationships and our reputation or result in defective products or services, legal claims and proceedings, liability and penalties under privacy laws and increased costs for security and remediation, each of which could adversely affect our business, reputation and financial statements. Although we maintain cyber risk insurance, damages and claims arising from such incidents may not be covered or may exceed the amount of any insurance available.
Risks Related to Our Acquisitions
Our growth strategy includes strategic acquisitions. We may not be able to consummate future acquisitions or successfully integrate recent and future acquisitions.
A portion of our growth has been attributed to acquisitions of strategic businesses. Since the beginning of 2016, through December 31, 2020, we have completed 17 acquisitions. We plan to continue making strategic acquisitions to enhance our global market position and broaden our product offerings. Although we have been successful with our acquisition strategy in the past, our ability to successfully effectuate acquisitions will be dependent upon a number of factors, including:
Our ability to identify acceptable acquisition candidates;
The impact of increased competition for acquisitions, which may increase acquisition costs, affect our ability to consummate acquisitions on favorable terms, and result in us assuming a greater portion of the seller’s liabilities;
Successfully integrating acquired businesses, including integrating the management, technological and operational processes, procedures and controls of the acquired businesses with those of our existing operations;
Adequate financing for acquisitions being available on terms acceptable to us;
Unexpected losses of key employees, customers and suppliers of acquired businesses;
13

Table of Contents
Mitigating assumed, contingent and unknown liabilities; and
Challenges in managing the increased scope, geographic diversity and complexity of our operations.
The process of integrating acquired businesses into our existing operations may result in unforeseen operating difficulties and may require additional financial resources and attention from management that would otherwise be available for the ongoing development or expansion of our existing operations. Furthermore, even if successfully integrated, the acquired business may not achieve the results we expected or produce expected benefits in the time frame planned. Failure to continue with our acquisition strategy and the successful integration of acquired businesses could have an adverse effect on our business, financial condition, results of operations and cash flows.
The indemnification provisions of acquisition agreements by which we have acquired companies may not fully protect us and as a result we may face unexpected liabilities.
Certain of the acquisition agreements by which we have acquired companies require the former owners to indemnify us against certain liabilities related to the operation of the company before we acquired it. In most of these agreements, however, the liability of the former owners is limited, and certain former owners may be unable to meet their indemnification responsibilities. We cannot assure you that these indemnification provisions will protect us fully or at all, and as a result we may face unexpected liabilities that adversely affect our financial statements.
Risks Related to Our Financial Condition
Certain environmental risks may cause us to be liable for costs associated with hazardous or toxic substance clean-up which may adversely affect our financial condition.
Our businesses, operations and facilities are subject to a number of federal, state, local and foreign environmental and occupational health and safety laws and regulations concerning, among other things, air emissions, discharges to waters and the use, manufacturing, generation, handling, storage, transportation and disposal of hazardous substances and wastes. Environmental risks are inherent in many of our manufacturing operations. Certain laws provide that a current or previous owner or operator of property may be liable for the costs of investigating, removing and remediating hazardous materials at such property, regardless of whether the owner or operator knew of, or was responsible for, the presence of such hazardous materials. In addition, the Comprehensive Environmental Response, Compensation and Liability Act generally imposes joint and several liability for clean-up costs, without regard to fault, on parties contributing hazardous substances to sites designated for clean-up under the Act. We have been named a potentially responsible party at several sites, which are the subject of government-mandated clean-ups. As the result of our ownership and operation of facilities that use, manufacture, store, handle and dispose of various hazardous materials, we may incur substantial costs for investigation, removal, remediation and capital expenditures related to compliance with environmental laws. While it is not possible to precisely quantify the potential financial impact of pending environmental matters, based on our experience to date, we believe that the outcome of these matters is not likely to have a material adverse effect on our financial position or future results of operations. In addition, new laws and regulations, new classification of hazardous materials, stricter enforcement of existing laws and regulations, the discovery of previously unknown contamination or the imposition of new clean-up requirements could require us to incur costs or become the basis for new or increased liabilities that could have a material adverse effect on our business, financial condition and results of operations. There can be no assurance that future environmental liabilities will not occur or that environmental damages due to prior or present practices will not result in future liabilities.
We are subject to a variety of litigation and other legal and regulatory proceedings in the course of our business that could adversely affect our financial statements.
We are subject to a variety of litigation and other legal and regulatory proceedings incidental to our business (or the business operations of previously owned entities), including claims for damages arising out of the use of products or services and claims relating to intellectual property matters, employment matters, tax matters, commercial disputes, competition and sales and trading practices, environmental matters, personal injury, insurance
14

Table of Contents
coverage and acquisition-related matters, as well as regulatory investigations or enforcement. These lawsuits may include claims for compensatory damages, punitive and consequential damages and/or injunctive relief. The defense of these lawsuits may divert our management’s attention, we may incur significant expenses in defending these lawsuits, and we may be required to pay damage awards or settlements or become subject to equitable remedies that could adversely affect our operations and financial statements. Moreover, any insurance or indemnification rights that we may have may be insufficient or unavailable to protect us against such losses. In addition, developments in proceedings in any given period may require us to adjust the loss contingency estimates that we have recorded in our financial statements, record estimates for liabilities or assets previously not susceptible of reasonable estimates or pay cash settlements or judgments. Any of these developments could adversely affect our financial statements in any particular period. We cannot assure you that our liabilities in connection with litigation and other legal and regulatory proceedings will not exceed our estimates or adversely affect our financial statements and reputation. However, based on our experience, current information and applicable law, we do not believe that any amounts we may be required to pay in connection with litigation and other legal and regulatory proceedings in excess of our reserves as of the date of this information statement will have a material effect on our financial statements.
Restrictions contained in our revolving credit facility and other debt agreements may limit our ability to incur additional indebtedness.
Our existing revolving credit facility and other debt agreements (each a “Debt Facility” and collectively, “Debt Facilities”) contain restrictive covenants, including restrictions on our ability to incur indebtedness. These restrictions could limit our ability to effectuate future acquisitions, limit our ability to pay dividends, limit our ability to make capital expenditures or restrict our financial flexibility. Our Debt Facilities contain covenants requiring us to achieve certain financial and operating results and maintain compliance with specified financial ratios. Our ability to meet the financial covenants or requirements in our Debt Facilities may be affected by events beyond our control, and we may not be able to satisfy such covenants and requirements. A breach of these covenants or our inability to comply with the financial ratios, tests or other restrictions contained in a Debt Facility could result in an event of default under one or more of our other Debt Facilities. Upon the occurrence of an event of default under a Debt Facility, and the expiration of any grace periods, the lenders could elect to declare all amounts outstanding under one or more of our other Debt Facilities, together with accrued interest, to be immediately due and payable. If this were to occur, our assets may not be sufficient to fully repay the amounts due under our Debt Facilities or our other indebtedness.
Our goodwill and other intangible assets represent a substantial proportion of our total assets and the impairment of such substantial goodwill and intangible assets could have a negative impact on our financial condition and results of operations.
Our total assets include substantial amounts of intangible assets, primarily goodwill. At December 31, 2020, goodwill and other intangible assets, net of accumulated amortization, totaled $6,848.6 million or 66% of our total assets. The goodwill results from our acquisitions, representing the excess of cost over the fair value of the net tangible and other identifiable intangible assets we have acquired. At a minimum, we assess annually whether there has been impairment in the value of our intangible assets. If future operating performance at one or more of our reporting units were to fall significantly below current levels, we could record, under current applicable accounting rules, a non-cash charge to operating income for goodwill or other intangible asset impairment. Any determination requiring the impairment of a significant portion of goodwill or other intangible assets would negatively affect our financial condition and results of operations.
Item 1B.    Unresolved Staff Comments
None.

15

Table of Contents
Item 2.    Properties
At December 31, 2020, the Company conducted business from office and operating facilities at owned and leased locations throughout the United States and select global markets. The Company’s leases a facility in Berwyn, Pennsylvania for its corporate headquarters.
The Company believes that all facilities have been adequately maintained, are in good operating condition, and are suitable for our current needs.
Item 3.    Legal Proceedings
Please refer to “Environmental Matters” in Part II, Item 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations and Note 13 to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for information regarding certain litigation matters.
The Company is subject to a variety of litigation and other legal and regulatory proceedings incidental to its business (or the business operations of previously owned entities), including claims for damages arising out of the use of the Company’s products or services and claims relating to intellectual property matters, employment matters, tax matters, commercial disputes, competition and sales and trading practices, environmental matters, personal injury, insurance coverage and acquisition-related matters, as well as regulatory investigations or enforcement. Based upon the Company’s experience, the Company does not believe that these proceedings and claims will have a material adverse effect on its results of operations, financial position or cash flows.
Item 4.    Mine Safety Disclosures
Not Applicable.
16

Table of Contents
PART II
Item 5.    Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
The principal market on which the Company’s common stock is traded is the New York Stock Exchange and it is traded under the symbol “AME.” On January 29, 2021, there were approximately 1,800 holders of record of the Company’s common stock.
Market price and dividend information with respect to the Company’s common stock is set forth below. Future dividend payments by the Company will be dependent on future earnings, financial requirements, contractual provisions of debt agreements and other relevant factors.
Under its share repurchase program, the Company repurchased approximately 55,000 shares of its common stock for $4.7 million in 2020 and approximately 133,000 shares of its common stock for $11.9 million in 2019.
Issuer Purchases of Equity Securities
The following table reflects purchases of AMETEK, Inc. common stock by the Company during the three months ended December 31, 2020:
PeriodTotal Number
of Shares
Purchased (1)(2)
Average Price
Paid per Share
Total Number
of Shares
Purchased as
Part of Publicly
Announced
Plan (2)
Approximate
Dollar Value of
Shares that
May Yet Be
Purchased Under
the Plan
October 1, 2020 to October 31, 2020— $— — $484,556,384 
November 1, 2020 to November 30, 20201,013 114.17 1,013 484,440,732 
December 1, 2020 to December 31, 2020— — — 484,440,732 
Total1,013 114.17 1,013 
_____________________
(1)Represents shares surrendered to the Company to satisfy tax withholding obligations in connection with employees’ share-based compensation awards.
(2)Consists of the number of shares purchased pursuant to the Company’s Board of Directors $500 million authorization for the repurchase of its common stock announced in February 2019. Such purchases may be effected from time to time in the open market or in private transactions, subject to market conditions and at management’s discretion.
17

Table of Contents
Securities Authorized for Issuance Under Equity Compensation Plan Information
The following table sets forth information as of December 31, 2020 regarding all of the Company’s existing compensation plans pursuant to which equity securities are authorized for issuance to employees and non-employee directors:
Plan categoryNumber of securities
to be issued
upon exercise of
outstanding options,
warrants and rights
(a)
Weighted average
exercise price of
outstanding options,
warrants and rights
(b)
Number of securities
remaining available
for future issuance
under equity
compensation plans
(excluding securities
reflected in column (a))
(c)
Equity compensation plans approved by security holders3,950,093 $65.16 11,084,782 
Equity compensation plans not approved by security holders
— — — 
Total3,950,093 65.16 11,084,782 
18

Table of Contents
Stock Performance Graph
The following graph and accompanying table compare the cumulative total stockholder return for AMETEK over the last five years ended December 31, 2020 with total returns for the same period for the Standard and Poor’s (“S&P”) 500 Index and S&P Industrials. AMETEK’s stock price is a component of both indices. The performance graph and table assume a $100 investment made on December 31, 2015 and reinvestment of all dividends. The stock performance shown on the graph below is based on historical data and is not necessarily indicative of future stock price performance.
COMPARISON OF FIVE-YEAR CUMULATIVE TOTAL RETURN
ame-20201231_g1.jpg
December 31,
201520162017201820192020
AMETEK, Inc.$100.00 $91.37 $137.04 $128.96 $191.21 $233.72 
S&P 500 Index100.00 111.96 136.40 130.42 171.49 203.04 
S&P Industrials100.00 118.86 143.86 124.74 161.38 179.23 
19

Table of Contents
Item 6.    Selected Financial Data
The following financial information for the five years ended December 31, 2020, has been derived from the Company’s consolidated financial statements. This information should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations and the consolidated financial statements and related notes thereto included elsewhere in this Annual Report on Form 10-K.
20202019201820172016
(In millions, except per share amounts)
Consolidated Operating Results (Year Ended December 31):
Net sales$4,540.0 $5,158.6 $4,845.9 $4,300.2 $3,840.1 
Operating income$1,027.9 $1,177.4 $1,075.5 $903.6 $791.0 
Net income$872.4 $861.3 $777.9 $681.5 $512.2 
Earnings per share:
Basic$3.80 $3.78 $3.37 $2.96 $2.20 
Diluted$3.77 $3.75 $3.34 $2.94 $2.19 
Dividends declared and paid per share$0.72 $0.56 $0.56 $0.36 $0.36 
Performance Measures and Other Data:
Operating income — Return on net sales22.6 %22.8 %22.2 %21.0 %20.6 %
— Return on average total assets10.2 %12.7 %13.1 %12.1 %11.5 %
Net income — Return on average total capital11.4 %11.7 %11.9 %11.6 %9.5 %
— Return on average stockholders’ equity16.8 %18.4 %18.8 %18.7 %15.7 %
EBITDA(1)
$1,421.6 $1,388.3 $1,267.7 $1,076.0 $966.0 
Ratio of EBITDA to interest expense(1)
16.5x15.7x15.4x11.0x10.2x
Depreciation and amortization$255.3 $234.0 $199.5 $183.2 $179.7 
Cash provided by operating activities$1,281.0 $1,114.4 $925.5 $833.3 $756.8 
Free cash flow(2)
$1,206.8 $1,012.1 $843.4 $758.2 $693.5 
Consolidated Financial Position
(At December 31):
Current assets$2,522.5 $2,025.8 $1,836.1 $1,934.7 $1,928.2 
Current liabilities$1,075.9 $1,425.9 $1,258.7 $1,138.7 $924.4 
Total debt, net$2,413.7 $2,768.7 $2,632.7 $2,174.3 $2,341.6 
Stockholders’ equity$5,949.3 $5,115.5 $4,241.9 $4,027.6 $3,256.5 
Stockholders’ equity per share$25.81 $22.33 $18.68 $17.42 $14.20 
Total debt as a percentage of capitalization28.9 %35.1 %38.3 %35.1 %41.8 %
Net debt as a percentage of capitalization(3)
16.8 %31.7 %34.9 %27.5 %33.3 %
20

Table of Contents
Notes to Selected Financial Data
______________________

(1)EBITDA represents earnings before interest, income taxes, depreciation and amortization. EBITDA is presented because the Company is aware that it is used by rating agencies, securities analysts, investors and other parties in evaluating the Company. It should not be considered, however, as an alternative to operating income as an indicator of the Company’s operating performance or as an alternative to cash flows as a measure of the Company’s overall liquidity as presented in the Company’s consolidated financial statements. Furthermore, EBITDA measures shown for the Company may not be comparable to similarly titled measures used by other companies. The following table presents the reconciliation of net income reported in accordance with U.S. generally accepted accounting principles (“GAAP”) to EBITDA:
Year Ended December 31,
20202019201820172016
(In millions)
Net income$872.4 $861.3 $777.9 $681.5 $512.2 
Add (deduct):
Interest expense86.1 88.5 82.2 98.0 94.3 
Interest income(2.1)(4.0)(1.7)(2.0)(1.1)
Income taxes209.9 208.5 209.8 115.3 180.9 
Depreciation101.3 101.4 85.4 82.0 74.8 
Amortization154.0 132.6 114.1 101.2 104.9 
Total adjustments549.2 527.0 489.8 394.5 453.8 
EBITDA$1,421.6 $1,388.3 $1,267.7 $1,076.0 $966.0 
(2)Free cash flow represents cash flow from operating activities less capital expenditures. Free cash flow is presented because the Company is aware that it is used by rating agencies, securities analysts, investors and other parties in evaluating the Company. The following table presents the reconciliation of cash flow from operating activities reported in accordance with U.S. GAAP to free cash flow:
Year Ended December 31,
20202019201820172016
(In millions)
Cash provided by operating activities$1,281.0 $1,114.4 $925.5 $833.3 $756.8 
Deduct: Capital expenditures(74.2)(102.3)(82.1)(75.1)(63.3)
Free cash flow$1,206.8 $1,012.1 $843.4 $758.2 $693.5 
(3)Net debt represents total debt, net minus cash and cash equivalents. Net debt is presented because the Company is aware that it is used by rating agencies, securities analysts, investors and other parties in evaluating the Company. The following table presents the reconciliation of total debt, net reported in accordance with U.S. GAAP to net debt:
December 31,
20202019201820172016
(In millions)
Total debt, net$2,413.7 $2,768.7 $2,632.7 $2,174.3 $2,341.6 
Less: Cash and cash equivalents(1,212.8)(393.0)(354.0)(646.3)(717.3)
Net debt1,200.9 2,375.7 2,278.7 1,528.0 1,624.3 
Stockholders’ equity5,949.3 5,115.5 4,241.9 4,027.6 3,256.5 
Capitalization (net debt plus stockholders’ equity)$7,150.2 $7,491.2 $6,520.6 $5,555.6 $4,880.8 
Net debt as a percentage of capitalization16.8 %31.7 %34.9 %27.5 %33.3 %

21

Table of Contents
Item 7.    Management’s Discussion and Analysis of Financial Condition and Results of Operations
This report includes forward-looking statements based on the Company’s current assumptions, expectations and projections about future events. When used in this report, the words “believes,” “anticipates,” “may,” “expect,” “intend,” “estimate,” “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such words. In this report, the Company discloses important factors that could cause actual results to differ materially from management’s expectations. For more information on these and other factors, see “Forward-Looking Information” herein.
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with “Item 1A. Risk Factors,” “Item 6. Selected Financial Data”, and the consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K.
Business Overview
AMETEK’s operations are affected by global, regional and industry economic factors. However, the Company’s strategic geographic and industry diversification, and its mix of products and services, have helped to mitigate the potential adverse impact of any unfavorable developments in any one industry or the economy of any single country on its consolidated operating results. In 2020, the Company was impacted by a weak global economy as a result of the COVID-19 pandemic, discussed below. In response to the weak global economy, the Company recorded 2020 realignment costs totaling $43.9 million (the “2020 realignment costs”). The 2020 realignment costs were composed of $35.5 million in severance costs for a reduction in workforce and $8.4 million of asset write-downs, primarily inventory. Contributions from the acquisitions of IntelliPower in January 2020, Pacific Design Technologies, Inc. (“PDT”) in September 2019, Gatan in October 2019, and a continued focus on and implementation of Operational Excellence initiatives, including the 2020 realignment actions, had a positive impact on the Company’s 2020 results.
Highlights of 2020 were:
In January 2020, the Company spent $116.5 million, net of cash acquired, to acquire IntelliPower, a leading provider of high-reliability, ruggedized uninterruptible power systems serving a wide range of defense and industrial applications.
In March 2020, the Company completed the sale of its Reading Alloys business (“Reading”) to Kymera International for net proceeds of $245.3 million in cash. The sale resulted in a pre-tax gain of $141.0 million recorded in other income, net and income tax expense of $31.4 million.
Cash flow provided by operating activities for 2020 was a record $1,281.0 million, an increase of $166.6 million or 14.9%, compared with $1,114.4 million in 2019.
Free cash flow (cash flow provided by operating activities less capital expenditures) increased to a record $1,206.8 million in 2020, compared with $1,012.1 million in 2019.
EBITDA (earnings before interest, income taxes, depreciation, and amortization) was a record $1,421.6 million in 2020, compared with $1,388.3 million in 2019.
The Company continued its emphasis on investment in research, development and engineering, spending $246.2 million in 2020. Sales from products introduced in the past three years were $1,074.0 million or 23.7% of net sales.

22

Table of Contents
Impact of COVID-19 Pandemic on our Business
Our business, operations and end markets were negatively impacted in 2020 by the global outbreak and rapid spread of COVID-19. As the situation rapidly evolved, we remained focused on safely serving our customers and protecting the health and safety of our employees. All of our manufacturing locations remain operational with enhanced safety measures to help keep our employees, contractors, customers, and communities safe. In compliance with government protocols, certain of the Company's employees were instructed to work from home until government mandated restrictions allow for a safe return to the workplace. Those working at our sites are required to follow appropriate procedures, including completion of multiple training sessions and performance of self- and on-site screenings, as well as adhere to our personal protective equipment, social distancing, and personal hygiene protocols. We are committed to safely maintaining plant operations and focusing on business continuity, while reliably supplying critical products to our customers.
During 2020, the COVID-19 pandemic resulted in a rapid decline in demand which impacted most of our end markets and geographies. We continue to experience end market volatility, however, orders have begun to return and stabilize in many of our end markets. Our financial position remains strong, however, we continue to closely monitor our fixed costs, capital expenditure plans, inventory, and capital resources to respond to changing conditions and to ensure we have the resources to meet our future needs. We believe that we will emerge from these events well positioned for long-term growth, though we cannot reasonably estimate the duration and severity of this global pandemic or its ultimate impact on the global economy and our business and results. Please refer to "Risk Factors", Part I, Item 1A of this Form 10-K for more information.
Results of Operations
The following table sets forth net sales and income by reportable segment and on a consolidated basis:
Year Ended December 31,
202020192018
(In thousands)
Net sales:
Electronic Instruments$2,989,928 $3,322,881 $3,028,959 
Electromechanical1,550,101 1,835,676 1,816,913 
Consolidated net sales$4,540,029 $5,158,557 $4,845,872 
Operating income and income before income taxes:
Segment operating income:
Electronic Instruments$770,620 $865,307 $782,144 
Electromechanical324,962 387,931 363,765 
Total segment operating income1,095,582 1,253,238 1,145,909 
Corporate administrative expenses(67,698)(75,858)(70,369)
Consolidated operating income1,027,884 1,177,380 1,075,540 
Interest expense(86,062)(88,481)(82,180)
Other income (expense), net140,487 (19,151)(5,615)
Consolidated income before income taxes$1,082,309 $1,069,748 $987,745 
______________________
The following “Results of Operations of the year ended December 31, 2020 compared with the year ended December 31, 2019” section presents an analysis of the Company’s consolidated operating results displayed in the Consolidated Statement of Income. A discussion regarding our financial condition and results of operations for the year ended December 31, 2019 compared to the year ended December 31, 2018 can be found under Item 7 in our
23

Table of Contents
Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed with the Securities and Exchange Commission on February 20, 2020.
Results of Operations for the year ended December 31, 2020 compared with the year ended December 31, 2019
Net sales for 2020 were $4,540.0 million, a decrease of $618.6 million or 12.0%, compared with net sales of $5,158.6 million in 2019. The decrease in net sales for 2019 was due to a 13% organic sales decline driven by a weak economy as a result of the COVID-19 pandemic, an unfavorable 3% from the Reading divestiture, partially offset by a 4% increase from acquisitions. EIG net sales were $2,989.9 million in 2020, a decrease of 10.0%, compared with $3,322.9 million in 2019. EMG net sales were $1,550.1 million in 2020, a decrease of 15.6%, compared with $1,835.7 million in 2019.
Total international sales for 2020 were $2,209.9 million or 48.7% of net sales, a decrease of $265.0 million or 10.7%, compared with international sales of $2,474.9 million or 48.0% of net sales in 2019. The decrease in international sales was primarily driven by lower sales in Europe as a result of the COVID-19 pandemic. Export shipments from the United States, which are included in total international sales, were $1,196.4 million in 2020, a decrease of $109.8 million or 8.4%, compared with $1,306.2 million in 2019.
Orders for 2020 were $4,624.4 million, a decrease of $649.9 million or 12.3% compared with $5,274.3 million in 2019. The decrease in orders was due to an 11% organic order decline driven by a weak economy as a result of the COVID-19 pandemic, an unfavorable 3% from the Reading divestiture, partially offset by a favorable 1% from acquisitions, and a favorable 1% effect of foreign currency translation. The Company’s backlog of unfilled orders at December 31, 2020 was a record $1,802.2 million, an increase of $84.3 million or 4.9%, compared with $1,717.9 million at December 31, 2019.
The Company recorded 2020 realignment costs totaling $43.9 million in the first quarter of 2020 (the “2020 realignment costs”). The 2020 realignment costs were composed of $35.5 million in severance costs for a reduction in workforce and $8.4 million of asset write-downs, primarily inventory, in response to the impact of a weak global economy as a result of the COVID-19 pandemic. See Note 18 to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for further details.
The 2020 realignment costs (in millions) reported in the consolidated statement of income as well as the impact on segment operating margins (in basis points) in 2020 are as follows:
2020
Realignment
Costs
Operating
Margins
EIG$22.8 (70)
EMG20.9 (130)
Total reported in segment operating income43.7 (100)
Selling, general and administrative expenses0.2 
Total reported in the consolidated statement of income$43.9 (100)
Segment operating income for 2020 was $1,095.6 million, a decrease of $157.6 million or 12.6%, compared with segment operating income of $1,253.2 million in 2019. The decrease in segment operating income was primarily due to the lower sales discussed above and the $43.7 million of 2020 realignment costs, partially offset by the benefits of the Company's Operational Excellence initiatives. Segment operating income, as a percentage of net sales, decreased to 24.1% in 2020, compared with 24.3% in 2019. The segment operating margins were negatively impacted by 100 basis points due to the 2020 realignment costs discussed above, partially offset by the benefits of the Company’s Operational Excellence initiatives.
Cost of sales for 2020 was $2,996.5 million or 66.0% of net sales, a decrease of $374.4 million or 11.1%, compared with $3,370.9 million or 65.3% of net sales for 2019. The cost of sales decrease was primarily due to the net sales decrease discussed above, partially offset by the increase from the 2020 realignment costs discussed above.
24

Table of Contents
Selling, general and administrative expenses for 2020 were $515.6 million or 11.4% of net sales, a decrease of $94.7 million or 15.5%, compared with $610.3 million or 11.8% of net sales in 2019. Selling, general and administrative expenses decreased primarily due to the decrease in net sales discussed above as well as lower discretionary spending as a result of the COVID-19 pandemic.
Consolidated operating income was $1,027.9 million or 22.6% of net sales for 2020, a decrease of $149.5 million or 12.7%, compared with $1,177.4 million or 22.8% of net sales in 2019. The consolidated operating income margins were negatively impacted by 100 basis points due to the 2020 realignment costs discussed above, partially offset by the benefits of the Company's Operational Excellence initiatives.
Other income, net was $140.5 million for 2020, an increase of $159.7 million, compared with $19.2 million of other expense in 2019. The increase in other income was primarily due to the gain on the sale of Reading of $141.0 million, higher defined benefit pension income of $7.5 million, and lower acquisition-related expenses.
The effective tax rate for 2020 was 19.4%, compared with 19.5% in 2019. See Note 9 to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for further details.
Net income for 2020 was a record $872.4 million, an increase of $11.1 million or 1.3%, compared with $861.3 million in 2019. The net of tax gain of $109.6 million on the sale of Reading and net of tax expense of $33.6 million on the 2020 realignment costs are included in net income in 2020.
Diluted earnings per share for 2020 were a record $3.77, an increase of $0.02 or 0.5%, compared with $3.75 per diluted share in 2019. The net of tax gain of $0.47 per diluted share on the sale of Reading and net of tax expense of $0.15 per diluted share on the 2020 realignment costs are included in diluted earnings per share in 2020.
Segment Results
EIG’s net sales totaled $2,989.9 million for 2020, a decrease of $333.0 million or 10.0%, compared with $3,322.9 million in 2019. The net sales decrease was due to a 15% organic sales decline driven by a weak global economy as a result of the COVID-19 pandemic, partially offset by the acquisitions of Gatan and IntelliPower.
EIG’s operating income was $770.6 million for 2020, a decrease of $94.7 million or 10.9%, compared with $865.3 million in 2019. EIG’s operating margins were 25.8% of net sales for 2020, compared with 26.0% of net sales in 2019. EIG’s decrease in operating income was primarily due to the decrease in sales discussed above as well as the $22.8 million of 2020 realignment costs, partially offset by the benefits of the Company's Operational Excellence initiatives. EIG’s 2020 operating margins were negatively impacted by 70 basis points due to the 2020 realignment costs discussed above.
EMG’s net sales totaled $1,550.1 million for 2020, a decrease of $285.6 million or 15.6%, compared with $1,835.7 million in 2019. The net sales decrease was due to a 10% organic sales decline driven by a weak global economy as a result of the COVID-19 pandemic, a favorable 2% impact from the PDT acquisition as well as an unfavorable 8% impact from the Reading divestiture.
EMG’s operating income was $325.0 million for 2020, a decrease of $62.9 million or 16.2%, compared with $387.9 million in 2019. EMG’s operating margins were 21.0% of net sales for 2020, compared with 21.1% of net sales in 2019. EMG’s decrease in operating income was primarily due to the decrease in sales discussed above as well as the $20.9 million of 2020 realignment costs, partially offset by benefits from the Group’s Operating Excellence initiatives. EMG’s 2020 operating margins were negatively impacted by 130 basis points due to the 2020 realignment costs discussed above.

25

Table of Contents
Liquidity and Capital Resources
Cash provided by operating activities totaled a record $1,281.0 million in 2020, an increase of $166.6 million or 14.9%, compared with $1,114.4 million in 2019. The increase in cash provided by operating activities for 2020 was primarily due to strong working capital management.
Free cash flow (cash flow provided by operating activities less capital expenditures) was a record $1,206.8 million in 2020, compared with $1,012.1 million in 2019. EBITDA (earnings before interest, income taxes, depreciation and amortization) was $1,421.6 million in 2020, compared with $1,388.3 million in 2019. Free cash flow and EBITDA are presented because the Company is aware that they are measures used by third parties in evaluating the Company. (See the “Notes to Selected Financial Data” included in Item 6 in this Annual Report on Form 10-K for a reconciliation of U.S. GAAP measures to comparable non-GAAP measures).
Cash provided by investing activities totaled $61.6 million in 2020, compared with cash used by investing activities of $1,150.9 million in 2019. In 2020, the Company paid $116.5 million, net of cash acquired, to purchase IntelliPower in January 2020 and received proceeds of $245.3 million from the sale of its Reading business. Additions to property, plant and equipment totaled $74.2 million in 2020, compared with $102.3 million in 2019.
Cash used by financing activities totaled $539.4 million in 2020, compared with $72.9 million of cash provided by financing activities in 2019. At December 31, 2020, total debt, net was $2,413.7 million, compared with $2,768.7 million at December 31, 2018. In 2020, short-term borrowings decreased $328.0 million, compared with an increase of $130.7 million in 2019. Long-term borrowings decreased $102.9 million in 2020, compared to no change in long-term borrowings in 2019.
In October 2018, the Company along with certain of its foreign subsidiaries amended and restated its Credit Agreement. The Credit Agreement amends and restates the Company’s existing $850 million revolving credit facility, which was due to expire in March 2021. The amended Credit Agreement consists of a five-year revolving credit facility in an aggregate principal amount of $1.5 billion with a final maturity date in October 2023. The revolving credit facility total borrowing capacity excludes an accordion feature that permits the Company to request up to an additional $500 million in revolving credit commitments at any time during the life of the Credit Agreement under certain conditions. The revolving credit facility provides the Company with additional financial flexibility to support its growth plans, including its acquisition strategy. At December 31, 2020, the Company had available borrowing capacity of $1,897.7 million under its revolving credit facility, including the $500 million accordion feature.
In the third quarter of 2020, an 80 million British pound ($102.9 million) 4.68% senior note matured and was paid. In the fourth quarter of 2019, $100 million of 6.30% senior notes matured and were paid. The debt-to-capital ratio was 28.9% at December 31, 2020, compared with 35.1% at December 31, 2019. The net debt-to-capital ratio (total debt, net less cash and cash equivalents divided by the sum of net debt and stockholders’ equity) was 16.8% at December 31, 2020, compared with 31.7% at December 31, 2019. The net debt-to-capital ratio is presented because the Company is aware that this measure is used by third parties in evaluating the Company. (See the “Notes to Selected Financial Data” included in Item 6 in this Annual Report on Form 10-K for a reconciliation of U.S. GAAP measures to comparable non-GAAP measures).
In 2020, the Company repurchased approximately 55,000 shares of its common stock for $4.7 million, compared with $11.9 million used for repurchases of approximately 133,000 shares in 2019. At December 31, 2020, $484.4 million was available under the Company’s Board of Directors authorization for future share repurchases. On February 12, 2019, the Company’s Board of Directors approved an increase of $500 million in the authorization for the repurchase of the Company’s common stock.
Additional financing activities for 2020 included cash dividends paid of $165.0 million, compared with $127.5 million in 2019. On February 12, 2020, the Company’s Board of Directors approved a 29% increase in the quarterly cash dividend on the Company’s common stock to $0.18 per common share from $0.14 per common share.
26

Table of Contents
Proceeds from the exercise of employee stock options were $64.9 million in 2020, compared with $90.4 million in 2019.
As a result of all of the Company’s cash flow activities in 2020, cash and cash equivalents at December 31, 2019 totaled $1,212.8 million, compared with $393.0 million at December 31, 2019. At December 31, 2020, the Company had $344.0 million in cash outside the United States, compared with $357.9 million at December 31, 2019. The Company utilizes this cash to fund its international operations, as well as to acquire international businesses. The Company is in compliance with all covenants, including financial covenants, for all of its debt agreements. The Company believes it has sufficient cash-generating capabilities from domestic and unrestricted foreign sources, available credit facilities and access to long-term capital funds to enable it to meet its operating needs and contractual obligations in the foreseeable future.
Subsequent Event
Effective February 11, 2021, the Company's Board of Directors approved an 11% increase in the quarterly cash dividend on the Company's common stock to $0.20 per common share from $0.18 per common share.
The following table summarizes AMETEK’s contractual cash obligations and the effect such obligations are expected to have on the Company’s liquidity and cash flows in future years at December 31, 2020.
Payments Due
Contractual Obligations (1)
TotalLess Than
One Year
More Than One Year
(In millions)
Long-term debt borrowings(2)
$2,347.6 $62.2 $2,285.4 
Revolving credit loans(3)
72.1 72.1 — 
Total debt(4)
2,419.7 134.3 2,285.4 
Interest on long-term fixed-rate debt454.4 71.4 383.0 
Non-cancellable operating leases(5)
190.1 50.3 139.8 
Purchase obligations(6)
526.1 462.1 32.0 
Total$3,590.3 $718.1 $2,840.2 
______________________
(1)The liability for uncertain tax positions was not included in the table of contractual obligations as of December 31, 2020 because the timing of the settlements of these uncertain tax positions cannot be reasonably estimated at this time. See Note 9 to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for further details.
(2)See Note 10 to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for further details.
(3)Although not contractually obligated, the Company expects to have the capability to repay the revolving credit loan within one year as permitted in the Credit Agreement. Accordingly, $72.1 million was classified as short-term debt at December 31, 2020.
(4)Excludes debt issuance costs of $6.0 million, of which $2.0 million is classified as current and $4.0 million is classified as long-term. See Note 10 to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for further details.
(5)The leases expire over a range of years from 2021 to 2035, except for a single land lease with 63 years remaining. Most of the leases contain renewal or purchase options, subject to various terms and conditions.
(6)Purchase obligations primarily consist of contractual commitments to purchase certain inventories at fixed prices.

27

Table of Contents
Other Commitments
The Company has standby letters of credit and surety bonds of $46.8 million related to performance and payment guarantees at December 31, 2020. Based on experience with these arrangements, the Company believes that any obligations that may arise will not be material to its financial position.

Internal Reinvestment
Capital Expenditures
Capital expenditures were $74.2 million or 1.6% of net sales in 2020, compared with $102.3 million or 2.0% of net sales in 2019. In 2020, approximately 73% of capital expenditures were for improvements to existing equipment or additional equipment to increase productivity and expand capacity. Capital expenditures in 2021 are expected to be approximately 2% of net sales, with a continued emphasis on spending to improve productivity.
Research, Development and Engineering
The Company is committed to, and has consistently invested in, research, development and engineering activities to design and develop new and improved products and solutions. Research, development and engineering costs before customer reimbursement were $246.2 million in 2020, $260.3 million in 2019 and $230.2 million in 2018. These amounts included research and development expenses of $158.9 million, $161.9 million and $141.0 million in 2020, 2019, and 2018, respectively. All such expenditures were directed toward the development of new products and solutions and the improvement of existing products and solutions.
Environmental Matters
Information with respect to environmental matters is set forth in Note 13 to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
Critical Accounting Policies and Estimates
Critical accounting policies are those policies that can have a significant impact on the presentation of the Company’s financial condition and results of operations and that require the use of complex and subjective estimates based on the Company’s historical experience and management’s judgment. Because of the uncertainty inherent in such estimates, actual results may differ materially from the estimates used. Below are the policies used in preparing the Company's financial statements that management believes are the most dependent upon the application of estimates and assumptions. A complete list of the Company’s significant accounting policies is in Note 1 to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
Business Combinations. The Company allocates the purchase price of an acquired company, including when applicable, the acquisition date fair value of contingent consideration between tangible and intangible assets acquired and liabilities assumed from the acquired business based on their estimated fair values, with the residual of the purchase price recorded as goodwill. Third party appraisal firms and other consultants are engaged to assist management in determining the fair values of certain assets acquired and liabilities assumed. Estimating fair values requires significant judgments, estimates and assumptions, including but not limited to: discount rates, future cash flows and the economic lives of trade names, technology, and customer relationships. These estimates are based on historical experience and information obtained from the management of the acquired companies and are inherently uncertain.
Goodwill and Other Intangible Assets. Goodwill and other intangible assets with indefinite lives, primarily trademarks and trade names, are not amortized; rather, they are tested for impairment at least annually. The Company can elect to perform a qualitative analysis to determine if it is more likely than not that the fair values of its reporting units are less than the respective carrying values of those reporting units. The
28

Table of Contents
Company elected to bypass performing the qualitative screen and performed the first step quantitative analysis of the goodwill impairment test in the current year. The Company may elect to perform the qualitative analysis in future periods.
The Company principally relies on a discounted cash flow analysis to determine the fair value of each reporting unit, which considers forecasted cash flows discounted at an appropriate discount rate. The Company believes that market participants would use a discounted cash flow analysis to determine the fair value of its reporting units in a sale transaction. The annual goodwill impairment test requires the Company to make a number of assumptions and estimates concerning future levels of revenue growth, operating margins, depreciation, amortization and working capital requirements, which are based on the Company’s long-range plan and are considered level 3 inputs. The Company’s long-range plan is updated as part of its annual planning process and is reviewed and approved by management. The discount rate is an estimate of the overall after-tax rate of return required by a market participant whose weighted average cost of capital includes both equity and debt, including a risk premium. While the Company uses the best available information to prepare its cash flow and discount rate assumptions, actual future cash flows or market conditions could differ significantly resulting in future impairment charges related to recorded goodwill balances. While there are always changes in assumptions to reflect changing business and market conditions, the Company’s overall methodology and the population of assumptions used have remained unchanged. In order to evaluate the sensitivity of the goodwill impairment test to changes in the fair value calculations, the Company applied a hypothetical 10% decrease in fair values of each reporting unit. The 2020 results (expressed as a percentage of carrying value for the respective reporting unit) showed that, despite the hypothetical 10% decrease in fair value, the fair values of the Company’s reporting units still exceeded their respective carrying values by 40% to 779%.
The impairment test for indefinite-lived intangibles other than goodwill (primarily trademarks and trade names) consists of a comparison of the fair value of the indefinite-lived intangible asset to the carrying value of the asset as of the impairment testing date. The Company can elect to perform a qualitative analysis to determine if it is more likely than not that the fair values of its indefinite-lived intangible assets are less than the respective carrying values of those assets. The Company elected to bypass performing the qualitative screen. The Company may elect to perform the qualitative analysis in future periods. The Company estimates the fair value of its indefinite-lived intangibles using the relief from royalty method using level 3 inputs, which is a widely used valuation technique for such assets. The fair value derived from the relief from royalty method is determined by applying a royalty rate to a projection of net revenues discounted using an appropriate discount rate. Each royalty rate is determined based on the profitability of the trade name to which it relates and observed market royalty rates. Certain impairment models have discount rates calculated based on a debt/equity cost of capital. While the Company uses the best available information to prepare its cash flow and discount rate assumptions, actual future cash flows or market conditions could differ significantly resulting in future impairment charges related to recorded intangible balances. While there are always changes in assumptions to reflect changing business and market conditions, the Company’s overall methodology and the population of assumptions used have remained unchanged.
The Company’s acquisitions have generally included a significant goodwill component and the Company expects to continue to make acquisitions. At December 31, 2020, goodwill and other indefinite-lived intangible assets totaled $4,977.9 million or 48.1% of the Company’s total assets. The Company completed its required annual impairment tests in the fourth quarter of 2020 and determined that the carrying values of the Company’s goodwill and indefinite-lived intangibles were not impaired. There can be no assurance that goodwill or indefinite-lived intangibles impairment will not occur in the future.
Pensions. The Company has U.S. and foreign defined benefit and defined contribution pension plans. The most significant elements in determining the Company’s pension income or expense are the assumed pension liability discount rate and the expected return on plan assets. The pension discount rate reflects the current interest rate at which the pension liabilities could be settled at the valuation date. At the end of each year, the Company determines the assumed discount rate to be used to discount plan liabilities. In
29

Table of Contents
estimating this rate for 2020, the Company considered rates of return on high-quality, fixed-income investments that have maturities consistent with the anticipated funding requirements of the plan. In estimating the U.S. and foreign discount rates, the Company’s actuaries developed a customized discount rate appropriate to the plans’ projected benefit cash flow based on yields derived from a database of long-term bonds at consistent maturity dates. The Company determines the expected long-term rate of return based primarily on its expectation of future returns for the pension plans’ investments. Additionally, the Company considers historical returns on comparable fixed-income and equity investments and adjusts its estimate as deemed appropriate.
Income Taxes. The process of providing for income taxes and determining the related balance sheet accounts requires management to assess uncertainties, make judgments regarding outcomes and utilize estimates. The Company conducts a broad range of operations around the world and is therefore subject to complex tax regulations in numerous international taxing jurisdictions, resulting at times in tax audits, disputes and potential litigation, the outcome of which is uncertain. Management must make judgments currently about such uncertainties and determine estimates of the Company’s tax assets and liabilities. To the extent the final outcome differs, future adjustments to the Company’s tax assets and liabilities may be necessary.
The Company assesses the realizability of its deferred tax assets, taking into consideration the Company’s forecast of future taxable income, available net operating loss carryforwards and available tax planning strategies that could be implemented to realize the deferred tax assets. Based on this assessment, management must evaluate the need for, and the amount of, valuation allowances against the Company’s deferred tax assets. To the extent facts and circumstances change in the future, adjustments to the valuation allowances may be required.
The Company assesses the uncertainty in its tax positions, by applying a minimum recognition threshold which a tax position is required to meet before a tax benefit is recognized in the financial statements. Once the minimum threshold is met, using a more likely than not standard, a series of probability estimates is made for each item to properly measure and record a tax benefit. The tax benefit recorded is generally equal to the highest probable outcome that is more than 50% likely to be realized after full disclosure and resolution of a tax examination. The underlying probabilities are determined based on the best available objective evidence such as recent tax audit outcomes, published guidance, external expert opinion, or by analogy to the outcome of similar issues in the past. There can be no assurance that these estimates will ultimately be realized given continuous changes in tax policy, legislation and audit practice. The Company recognizes interest and penalties accrued related to uncertain tax positions in income tax expense.
Recent Accounting Pronouncements
See Note 2, Recent Accounting Pronouncements, to the Company’s Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for information regarding recently issued accounting pronouncements.
Forward-Looking Information
Certain matters discussed in this Form 10-K are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (“PSLRA”), which involve risk and uncertainties that exist in the Company’s operations and business environment and can be affected by inaccurate assumptions, or by known or unknown risks and uncertainties. Many such factors will be important in determining the Company’s actual future results. The Company wishes to take advantage of the “safe harbor” provisions of the PSLRA by cautioning readers that numerous important factors in some cases have caused, and in the future could cause, the Company’s actual results to differ materially from those expressed in any forward-looking statements made by, or on behalf of, the Company. Some, but not all, of the factors or uncertainties that could cause actual results to differ from present expectations are set forth above and under Item 1A. Risk Factors. The Company undertakes no obligation to
30

Table of Contents
publicly update any forward-looking statements, whether as a result of new information, subsequent events or otherwise, unless required by the securities laws to do so.
Item 7A.    Quantitative and Qualitative Disclosures About Market Risk
The Company’s primary exposures to market risk are fluctuations in interest rates, foreign currency exchange rates and commodity prices, which could impact its financial condition and results of operations. The Company addresses its exposure to these risks through its normal operating and financing activities. The Company’s differentiated and global business activities help to reduce the impact that any particular market risk may have on its operating income as a whole.
The Company’s short-term debt carries variable interest rates and generally its long-term debt carries fixed rates. These financial instruments are more fully described in the Notes to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
The foreign currencies to which the Company has the most significant exchange rate exposure are the Euro, the British pound, the Japanese yen, the Chinese renminbi, the Canadian dollar, and the Mexican peso. Exposure to foreign currency rate fluctuation is modest, monitored, and when possible, mitigated through the use of local borrowings and occasional derivative financial instruments in the foreign currency affected. The effect of translating foreign subsidiaries’ balance sheets into U.S. dollars is included in other comprehensive income within stockholders’ equity. Foreign currency transactions have not had a significant effect on the operating results reported by the Company because revenues and costs associated with the revenues are generally transacted in the same foreign currencies.
The primary commodities to which the Company has market exposure are raw material purchases of nickel, aluminum, copper, steel, titanium, and gold. Exposure to price changes in these commodities are generally mitigated through adjustments in selling prices of the ultimate product and purchase order pricing arrangements, although forward contracts are sometimes used to manage some of those exposures.
Based on a hypothetical ten percent adverse movement in interest rates, commodity prices or foreign currency exchange rates, the Company’s best estimate is that the potential losses in future earnings, fair value of risk-sensitive financial instruments and cash flows are not material, although the actual effects may differ materially from the hypothetical analysis.
31

Table of Contents
Item 8.    Financial Statements and Supplementary Data
Page
Index to Financial Statements (Item 15(a)(1))
Financial Statement Schedules (Item 15(a)(2))
Financial statement schedules have been omitted because either they are not applicable, or the required information is included in the financial statements or the notes thereto.
32

Table of Contents
Management’s Responsibility for Financial Statements
Management has prepared and is responsible for the integrity of the consolidated financial statements and related information. The statements are prepared in conformity with U.S. generally accepted accounting principles consistently applied and include certain amounts based on management’s best estimates and judgments. Historical financial information elsewhere in this report is consistent with that in the financial statements.
In meeting its responsibility for the reliability of the financial information, management maintains a system of internal accounting and disclosure controls, including an internal audit program. The system of controls provides for appropriate division of responsibility and the application of written policies and procedures. That system, which undergoes continual reevaluation, is designed to provide reasonable assurance that assets are safeguarded, and records are adequate for the preparation of reliable financial data.
Management is responsible for establishing and maintaining adequate internal control over financial reporting. AMETEK, Inc. maintains a system of internal controls that is designed to provide reasonable assurance as to the fair and reliable preparation and presentation of the consolidated financial statements; however, there are inherent limitations in the effectiveness of any system of internal controls.
Management recognizes its responsibility for conducting the Company’s activities according to the highest standards of personal and corporate conduct. That responsibility is characterized and reflected in a code of business conduct for all employees and in a financial code of ethics for the Chief Executive Officer and Senior Financial Officers, as well as in other key policy statements publicized throughout the Company.
The Audit Committee of the Board of Directors, which is composed solely of independent directors who are not employees of the Company, meets with the independent registered public accounting firm, the internal auditors and management to satisfy itself that each is properly discharging its responsibilities. The report of the Audit Committee is included in the Company’s Proxy Statement for the 2021 Annual Meeting of Stockholders. Both the independent registered public accounting firm and the internal auditors have direct access to the Audit Committee.
The Company’s independent registered public accounting firm, Ernst & Young LLP, is engaged to render an opinion as to whether management’s financial statements present fairly, in all material respects, the Company’s financial position and operating results. This report is included herein.
Management’s Report on Internal Control over Financial Reporting
Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in the Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, AMETEK, Inc. conducted an evaluation of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2020 based on criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on that evaluation, our management concluded that the Company’s internal control over financial reporting was effective as of December 31, 2020.
The Company acquired IntelliPower in January 2020. As permitted by the U.S. Securities and Exchange Commission staff interpretative guidance for newly acquired businesses, the Company excluded IntelliPower from management’s assessment of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2020. IntelliPower constituted 1.1% of total assets as of December 31, 2020 and 0.6% of net sales for the year then ended.
The Company’s internal control over financial reporting as of December 31, 2020 has been audited by Ernst & Young LLP, an independent registered public accounting firm, as stated in their report, which is included herein.
/s/ DAVID A. ZAPICO
/s/ WILLIAM J. BURKE
Chairman of the Board and Chief Executive OfficerExecutive Vice President – Chief Financial Officer
February 18, 2021
33

Table of Contents
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
ON INTERNAL CONTROL OVER FINANCIAL REPORTING
To the Board of Directors and Stockholders of AMETEK, Inc.:
Opinion on Internal Control over Financial Reporting
We have audited AMETEK, Inc.’s internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, AMETEK, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on the COSO criteria.
As indicated in the accompanying Management’s Report on Internal Control over Financial Reporting, management’s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of IntelliPower, which is included in the 2020 consolidated financial statements of the Company and constituted 1.1% of total assets as of December 31, 2020 and 0.6% of net sales for the year then ended. Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of IntelliPower.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of AMETEK, Inc. as of December 31, 2020 and 2019, the related consolidated statements of income, comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2020, and the related notes and our report dated February 18, 2021 expressed an unqualified opinion thereon.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.
Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ ERNST & YOUNG LLP
Philadelphia, Pennsylvania
February 18, 2021
34

Table of Contents
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
ON FINANCIAL STATEMENTS
To the Board of Directors and Stockholders of AMETEK, Inc.:
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of AMETEK, Inc. (the Company) as of December 31, 2020 and 2019, the related consolidated statements of income, comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2020, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February 18, 2021 expressed an unqualified opinion thereon.

Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing a separate opinion on the critical audit matters or on the accounts or disclosures to which they relate.
35

Table of Contents
Accounting for Acquisitions
Description of the Matter
As described in Note 6 to the consolidated financial statements, the Company completed the acquisition of Gatan in October 2019 for consideration of $938.5 million, net of cash acquired. This acquisition has been accounted for as a business combination and the finalization of the acquisition accounting was completed in 2020 which included recording adjustments within the measurement period for acquired intangible assets.
Auditing the Company’s finalization of the estimated fair value of the acquired intangible assets for the acquisition of Gatan was complex and highly judgmental due to subjectivity of the significant assumptions used by management in the valuation of acquired identifiable intangible assets. In particular, the inputs to the valuation models used to estimate the fair value of acquired identifiable intangible assets were inherently uncertain and generally unobservable, and the resulting valuations were sensitive to changes in the underlying significant assumptions. The significant assumptions used included discount rates, royalty rates and certain assumptions that form the basis of the forecasted future cash flows, including revenue growth rates, earnings before interest, taxes, depreciation and amortization (EBITDA) margins and estimated economic lives. These significant assumptions are forward looking and could be affected by future economic or market conditions.
How We Addressed the Matter in Our Audit
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s finalization of the estimated fair value of the acquired intangible assets of Gatan. For example, we tested controls over the valuation of acquired identifiable intangible assets including controls over management’s review of the valuation models and the significant assumptions described above.
To test the finalization of the estimated fair value of the acquired intangible assets, we performed audit procedures that included, among others, assessing the fair value methodologies utilized by management and the significant assumptions discussed above, including the underlying data used in the analyses. For example, when evaluating the significant assumptions, we compared them to current financial and operating plans, market and industry studies, historical trends, and assumptions used in prior periods. We also performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value estimates of the acquired identifiable intangible assets that would result from changes in the assumptions. We involved our valuation specialists to assist in evaluating certain significant assumptions and valuation methodologies used by the Company.
Impairment Assessment of Indefinite Lived Intangible Assets (other than Goodwill)
Description of the Matter
At December 31, 2020, the Company’s indefinite lived intangible assets (other than goodwill) totaled $753.0 million, consisting of trademarks and trade names. As described in Note 1 to the consolidated financial statements, indefinite lived intangible assets are not amortized but are tested for impairment at least annually in the Company’s fourth quarter.
Auditing management’s indefinite lived intangible asset impairment tests was complex and highly judgmental due to the significant measurement uncertainty in estimating the fair value of the trademarks and trade names. In particular, the fair value estimates were sensitive to significant assumptions such as discount rate, forecasted revenues and royalty rates, which are affected by expectations about future market or economic conditions.
36

Table of Contents
How We Addressed the Matter in Our Audit
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s indefinite lived intangible asset impairment process. For example, we tested controls over management’s review of the valuation models and significant assumptions, including forecasted financial information, as well as management’s controls to validate that the data used in the valuations was complete and accurate.
To test the estimated fair value of the Company’s indefinite lived intangible assets, we performed audit procedures that included, among others, assessing the fair value methodologies utilized by management and the significant assumptions discussed above, including the underlying data used in the analyses. For example, when evaluating the significant assumptions, we compared them to current financial and operating plans, market and industry studies, historical trends, and other assumptions used in prior periods. We also assessed the historical accuracy of management’s forecasts and performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value estimates of the trademarks and trade names that would result from changes in the assumptions. We involved our valuation specialists to assist in evaluating the discount rate, royalty rate and valuation methodologies used by the Company.

/s/ ERNST & YOUNG LLP
We have served as the Company’s auditor since 1930.
Philadelphia, Pennsylvania
February 18, 2021
37

Table of Contents
AMETEK, Inc.
Consolidated Statement of Income
(In thousands, except per share amounts)
Year Ended December 31,
202020192018
Net sales$4,540,029 $5,158,557 $4,845,872 
Cost of sales2,996,515 3,370,897 3,186,310 
Selling, general and administrative515,630 610,280 584,022 
Total operating expenses3,512,145 3,981,177 3,770,332 
Operating income1,027,884 1,177,380 1,075,540 
Interest expense(86,062)(88,481)(82,180)
Other income (expense), net140,487 (19,151)(5,615)
Income before income taxes1,082,309 1,069,748 987,745 
Provision for income taxes209,870 208,451 209,812 
Net income$872,439 $861,297 $777,933 
Basic earnings per share$3.80 $3.78 $3.37 
Diluted earnings per share$3.77 $3.75 $3.34 
Weighted average common shares outstanding:
Basic shares229,435 227,759 230,823 
Diluted shares231,150 229,395 232,712 
See accompanying notes.
38

Table of Contents
AMETEK, Inc.
Consolidated Statement of Comprehensive Income
(In thousands)
Year Ended December 31,
202020192018
Net income$872,439 $861,297 $777,933 
Other comprehensive (loss) income:
Amounts arising during the period – gains (losses), net of tax (expense) benefit:
Foreign currency translation:
Translation adjustments64,521 23,692 (72,112)
Change in long-term intercompany notes16,695 (5,999)(16,569)
Net investment hedge instruments gain (loss), net of tax of $14,787, $581 and ($12,384) in 2020, 2019 and 2018, respectively
(45,716)(1,803)38,452 
Defined benefit pension plans:
Net actuarial loss, net of tax of $8,637, $767 and ($18,825) in 2020, 2019 and 2018, respectively
(18,733)(10,522)(75,253)
Amortization of net actuarial loss, net of tax of ($3,539), ($3,505) and ($2,716) in 2020, 2019 and 2018, respectively
11,940 12,180 9,313 
Amortization of prior service costs, net of tax of $7, ($83) and $1,154 in 2020, 2019 and 2018, respectively
(36)401 (5,639)
Unrealized holding gain (loss) on available-for-sale securities:
Unrealized gain (loss), net of tax   (104)
Other comprehensive income (loss)28,671 17,949 (121,912)
Total comprehensive income$901,110 $879,246 $656,021 
See accompanying notes.
39

Table of Contents
AMETEK, Inc.
Consolidated Balance Sheet
(In thousands, except share amounts)
December 31,
20202019
ASSETS
Current assets:
Cash and cash equivalents$1,212,822 $393,030 
Receivables597,472 744,760 
Inventories, net559,171 624,567 
Other current assets153,005 263,414 
Total current assets2,522,470 2,025,771 
Property, plant and equipment, net526,530 548,908 
Right of use assets, net167,233 179,679 
Goodwill4,224,906 4,047,539 
Other intangibles, net2,623,719 2,762,872 
Investments and other assets292,625 279,790 
Total assets$10,357,483 $9,844,559 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Short-term borrowings and current portion of long-term debt, net$132,284 $497,449 
Accounts payable360,370 377,219 
Customer advanced payments194,633 156,818 
Income taxes payable38,896 30,292 
Accrued liabilities and other349,732 364,080 
Total current liabilities1,075,915 1,425,858 
Long-term debt, net2,281,441 2,271,292 
Deferred income taxes533,478 536,140 
Other long-term liabilities517,303 495,777 
Total liabilities4,408,137 4,729,067 
Stockholders’ equity:
Preferred stock,$0.01 par value; authorized 5,000,000 shares; none issued
  
Common stock, $0.01 par value; authorized 800,000,000 shares; issued: 2020 – 266,746,248 shares; 2019 – 265,583,732 shares
2,676 2,662 
Capital in excess of par value921,752 832,821 
Retained earnings7,094,656 6,387,612 
Accumulated other comprehensive loss(504,468)(533,139)
Treasury stock: 2020 – 36,227,061 shares; 2019 – 36,500,908 shares
(1,565,270)(1,574,464)
Total stockholders’ equity5,949,346 5,115,492 
Total liabilities and stockholders’ equity$10,357,483 $9,844,559 
See accompanying notes.
40

Table of Contents
AMETEK, Inc.
Consolidated Statement of Stockholders’ Equity
(In thousands)
Year Ended December 31,
202020192018
Capital stock
Preferred stock, $0.01 par value
$— $— $— 
Common stock, $0.01 par value
Balance at the beginning of the year2,662 2,640 2,631 
Shares issued14 22 9 
Balance at the end of the year2,676 2,662 2,640 
Capital in excess of par value
Balance at the beginning of the year832,821 706,743 660,894 
Issuance of common stock under employee stock plans47,366 85,684 18,534 
Share-based compensation costs41,565 40,394 27,315 
Balance at the end of the year921,752 832,821 706,743 
Retained earnings
Balance at the beginning of the year6,387,612 5,653,811 5,002,419 
Net income872,439 861,297 777,933 
Cash dividends paid(165,035)(127,496)(128,911)
Adoption of ASU 2016-13(360)  
Other  2,370 
Balance at the end of the year7,094,656 6,387,612 5,653,811 
Accumulated other comprehensive (loss) income
Foreign currency translation:
Balance at the beginning of the year(286,248)(302,138)(251,909)
Translation adjustments64,521 23,692 (72,112)
Change in long-term intercompany notes16,695 (5,999)(16,569)
Net investment hedge instruments (loss) gain, net of tax of $14,787, $581 and ($12,384) in 2020, 2019 and 2018, respectively
(45,716)(1,803)38,452 
Balance at the end of the year(250,748)(286,248)(302,138)
Defined benefit pension plans:
Balance at the beginning of the year(246,891)(